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Abstract
Herringshaw, Michael. MS. The University of Memphis. August, 2015.
Advancing the Early Detection of Atrial Fibrillation through In Silico Tissue
Modeling. Major Professor: Amy deJongh Curry, Ph.D.
Atrial fibrillation (AF) is a widely prevalent arrhythmia which affects
approximately 4.5 million people in Europe and the US, reducing quality of life
and increasing risk of stroke and death. Considerable research effort is currently
directed to this arrhythmia because the mechanisms causing its initiation,
maintenance, and termination are not well understood. This study addresses, at
a tissue level, the basic descriptors of atrial fibrillation, known causes, and a
model to utilize in analyzing heart wave characteristics such as propagation
velocity, action potential duration and others for potential use in developing early
detection methods of AF. The tissue model methodology, based on epicardial
tissue and kinetics from a cellular model, utilized the MATLAB PDEPE solver on
a 1 x .0011cm tissue strip, enabling research into complex action potential (AP)
and AP propagation characteristics. The model represented left atrial tissue sinus
rhythm (SR) and AF states as defined in Grandi et al.23 with comprehensive state
variables and ionic currents as well as complete cellular physiology including
excitation contraction coupling with sarcoplasmic reticulum Ca2+ ATPase,
calcium-induced calcium release, Ca2+ and Na+ buffer fluxes, subcellular sections
and diffusion factors. Based on following the nonlinear response cascade of the
potassium channels during the progression to AF, the tissue model study
provides insight into wave propagation velocity, atrial AP amplitude, action
potential duration, non-refractory periods, in addition to other wave
ii

characteristics through rates of change, greater than 50%. Regardless of the
many known forms of AF, which often involve polygenetic and other cardiac
pathologies, this human atrial tissue model study, with its completeness of
cardiac cell and tissue representation, provides a basis for further analysis
research and modeling because the cardiac structures used can be modified to
represent or independently model other potential cardiac pathologies that
represent early risk warning indicators.
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Chapter 1. Introduction
1.1 Atrial Fibrillation Background
Various forms of AF currently affect 1% of the population, 8% of those over
age 8046, and are expected to impact more than 16 million Americans by 205051.
Due to the wide heterogeneity of its underlying pathophysiology, its different
symptomatic impact on each patient, and the possibility of different therapeutic
options, AF represents a great challenge for clinicians17. Some genetic forms of

Fig. 1 ECG of atrial fibrillation (top) and
normal sinus rhythm (bottom). The purple
arrow indicates a P wave, which is lost in
atrial fibrillation.37
AF, such as those associated with the 10q22-q24 chromosomes, have no
associated electrocardiographic abnormalities33,35. In the electrocardiogram, AF
is characterized by rapid atrial activity that is irregular in timing and morphology
(Fig. 1). Discrete P waves are absent and replaced by an oscillating baseline that
consists of low-amplitude fibrillatory f-waves17. Human and experimental studies
have shown that effective shortening of the AP refractory period, the period when
the cardiac tissue cannot be depolarized, is an essential feature of atrial
fibrillation17.
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At the atrial level, characterization of fibrillatory f-waves during AF with
spectral analysis of P wave signal averaging, using sinus rhythm as a baseline,
has been successfully applied to monitor and predict outcome of antiarrhythmic
drug therapy and cardioversion17. Electrocardiographic imaging is also being
used to discern atrial heart wave behavior32.
The classification scheme used for AF is 1) paroxysmal AF, i.e. AF with
spontaneous interruption generally within 7 days but mostly in 24-48 hours; 2)
persistent AF, i.e. AF that, independently of its duration, does not interrupt
spontaneously, but with therapeutical intervention (pharmacological or electrical);
and 3) permanent or chronic AF, i.e. AF in which interruption attempts have not
been made or, if made they were not successful, i.e. failed restoration of sinus
rhythm17. AF is also an electrical disruption of cardiac excitation and propagation
whose initiation depends on the presence of triggers46 and maintenance requires
appropriate arrhythmogenic substrate36. This study is an effort to address
prediction of class 1 and 2 AF based on known electro-chemical cardiac
properties.
AF has been characterized as having focal triggers in the pulmonary vein
interface within the heart and left atrium36. The triggers manifest themselves as
early after-depolarization (EAD) and delayed after-depolarization (DAD) with
associated electrical waves. Maintenance of AF is through wave breaks and
associated points of singularity (PS) in heterogeneous tissue. The points of
singularity (PS) define anchors for wave breaks, referred to as wavelets, in
heterogeneous repolarizing cardiac tissue. These wavelets create re-entrant
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points or points of excitation outside the normal left atrial sinus rhythm. As AF
progresses from paroxysmal to persistent the triggers move from the left to the
right atria believed to be caused by the down regulation of transient outward K+
current (Ito)52, inward calcium current (ICa) and inward sodium current (INa) ion
channels in the right and left atrial myocytes36. This study addresses the left atrial
tissue but the structure can be applied to the right atrial and other cardiac
regions.
Cellular and molecular behavior involved in AF is influenced by signaling
factors, ionic concentrations and stimulus currents36. Cardiac ion channels,
involved in AF, are generally classified as passive channels, metabolic pumps
utilizing adenosine triphosphate (ATP), or exchangers leveraging chemical
gradients. Selectivity is controlled through protein structure. Activity control is via
voltage-activated gating states (open, closed, inactive) through Na+, Ca2+, some
K+ channels and, ligand-gated through acetylcholine (ACh) and ATP among
others. Mechanical stretch is also a determining ionic factor5,16,36. This study
focuses on these ionic flows.
Additionally, AF is increasingly recognized as having genetic
underpinnings25,15,33 (Appendix B). AF is characterized by association with other
cardiac disease states, which applies to 70-85% of AF cases, or without a known
association and etiology, which is 15-30% of AF cases, also known as lone AF33.
Lone AF causation is suspected of being genetically determined. Therefore
identifying patients with genetic defects predisposing to AF provides a unique
opportunity to potentially address lone AF or AF in and of itself33.
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Lone AF has been isolated in monogenic and polymorphic forms, with
monogenic forms related to genes KCNQ1, KCNE2, KCNJ2, KCNA5, SCN5A,
and CJA5 among others. Atrial flutter, paroxysmal AF, and chronic lone AF have
been associated with these genes with most associations being paroxysmal
AF33. In some cases KCNQ1 is linked to familial AF by increasing the slow
activating potassium current (IKs)33,35 expression and currents. HERG-37 genetic
defects affect IKs and repolarization in the cardiac tissue and impair the heart’s
ability to respond to changes in rate14,33. Short QT syndrome genetic defects in
inward rectifier K+ current (IKi) channels are believed to cause familial AF14,33.
ATP reductions and Na+/K+ ATPase impacts of late sodium inward current (INaL)
create appearances of K+ related fibrillations10,33,63.
ATP driven potassium channel (IKATP) gene Kir6.2 K23 Allele is a risk factor
in 50% of the population, but not a predictor, for transition from hypertension
stress load to sub clinical maladaptive cardiac remodeling15,33. Vulnerability to
arrhythmia is created by the inability of IKATP channels to safe guard against
adrenergic stress induced ectopy15,33 and in general IKATP challenges are
believed to cause lone AF15,33. Additionally magnesium (Mg2+) acts to reduce the
inhibitory impact of ATP on K+ expression that enables IKATP to have a positive
impact on heart conditioning16,33, which is believed to protect the heart against
fibrillation.
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There are many identified genetic drivers of inherited AF as well as lone AF –
which in some cases are one and the same. The primary impacts (Fig. 2 and
Appendix B) of the genetic defect for AF are gain of function in the Iks current via

Fig. 2 Cardiac action potential (red tracing) and atrial ionic impacts in AF33 in
the action potential (see Appendix C for definitions).

reduced APD and refractory period, the potassium fast transient outward current
(Itof) via reduced AP duration (APD) and refractory period, and loss of function in
the ultra-rapid delayed rectifier potassium current (Ikur) via lengthened APD and
early after depolarization33 and rapidly activating potassium current (Ikr) through
decreased gap junction density33. Other research38 suggests loss of function in
calcium currents (ICaL), Ito, IKur and sarcoplasmic reticulum Ca2+ ATPase
(SERCA), along with gain of function in IKi, IKs, and Na+ Ca2+ exchanger current
(Incx) based on an assumed mixed etiology polygenic AF as reported by Grandi et
5

al.23 in their modeling. The tissue model utilized in this study is able to represent
most if not all these conditions.
General consensus is that AF begets AF62 – unresolved lone paroxysmal AF
leads to more severe and chronic fibrillation and heart disease42,43,33,35 through
various forms of cardiac remodeling and ion channel protein transcription
alterations.
The elements used in atrial tissue models to analyze AF include the ionic
channels of the left atrial chamber14,17,29,46,47, the ionic densities in epicardial39,86
heart tissue, ion channel specificity and expression 35, anisotropic propagation,
propagation safety factor, cellular temperature, tissue heterogeneity, ion
chemical balance and polarization, and mutual entrainment within the sinoatrial
node (SA), and atrioventricular node (AV) and bundle of His (NH) cardiac
structures16,36.
In summary, AF is a significant pathology and there is growing evidence that,
at least for some portion of AF, AF has unique genetic causes. In addition to
those unique genetic causes, AF is believed to be associated with degenerative
heart remodeling that leads to further cardiac pathologies including more severe
forms of AF.
There is significant motivation for research into early detection and
assessment of this condition beyond genetic testing that could alert individuals to
risk factors. The tissue model developed in this research is intended to provide
more tools for early AF detection.
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1.2 Tissue Model Study Objective
The underlying changes in atrial AP can lead to AF beginning much earlier
and at levels below that which cannot be detected by either conventional
methods such as electrocardiogram (ECG), or human discomfort such as
“fluttering in the chest”. Scientific research has determined that AF is potentially
initiated in its inception through genetic alterations at the cellular level through
established and documented ion channel structures. Ionic cellular models23,26,28
have been developed that represent mathematically, the ionic channel conditions
that are believed needed for establishment of chronic AF (cAF). ECGs and
patient self-diagnostics can detect AF in all forms after AF remodeling has
developed to a significant level. The hypothesis is that an atrial tissue model can
be developed to model heart wave in sinus rhythm and atrial fibrillation
conditions, as defined by Grandi et al.23 based on wave form, amplitude, and
frequency. Detection/prediction, along with genetic testing, can be made before
ECGs and patient self-diagnostics, with the critical benefit that the degenerative
cardiac remodeling can potentially be arrested early, leading to the delay and
prevention of the development of AF. The objective is to develop an ionic and
physiologically accurate model that will provide heart wave analysis of the
underlying changes induced by AF remodeling in Ca2+, K+, and Na+ parameters
as defined by Grandi et al.23. With appropriate and developing technology, this
model can assist in early detection/prediction based on any of several signal
analysis algorithms such as rhythm, regularity, synchronization, or morphology
based analysis, of the simulated atrial AP and AP propagation wave forms.
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Chapter 2 Methods
2.1 Model Physiology
The tissue model developed in this study is based on concepts from a
cellular human atrial model, developed by Grandi et al.23 (Fig. 3A) validated for
sinus rhythm and chronic AF (Table 1 and Appendix A). The model is one of the
most advanced models available, in terms of detailed ionic channel kinetics and
excitation contraction coupling, found in the literature research. The heart wave
propagation was modeled based on the concepts of the Livshitz et al.12 guinea
pig myocyte model (Fig. 3B). The Livshitz model concepts were modified for
alignment with the Grandi concepts, and both concepts were modified to
accommodate atrial tissue propagation and key ionic variables (Fig. 10).
The model developed has the following elements considered key based on
literature12,23,26,28,34 review: 1) accurately reflects Ca2+ dependent Ca2+ release in
human heart representation80; 2) uses realistic parameters, particularly those that

A - Atrial Cell Model28 Modified

B - Atrial Tissue Model12

Fig. 3 Pathological atrial cell (A) and tissue (B) concepts used in study. Refer
to Appendix 3 for definitions.
concern Ca2+ transport from the cytosol; 3) comes to a steady state, which is key
in measuring parameter impacts in relevant physiological ranges ; 4) simulates
basic excitation-contraction coupling phenomena; 5) includes a sub-sarcolemma
8

compartment in addition to the two commonly formulated compartments
(junctional and bulk) because ion channels in the membrane sense ion
concentrations that differ from the bulk; 6) uses realistic cytosolic buffering
parameters; 7) includes sarcoplasmic reticulum (SR) Ca2+ pump; -a scheme for
Na+-Ca2+ exchange transport that is [Na+]I dependent and allosterically regulated
by [Ca2+]I; 8) uses a practical model of SR Ca2+ release including both
inactivation/adaption; 9) includes SR Ca2+ load dependence, via a Markov model
recognition of Iks ability to form an available reserve when Ikr, the rapid delay
rectifier is reduced through disease or drug; 10) includes Mg2+ handling which
impacts IKATP; and 11) has extensive K+ channel representation. The requirement
for these elements includes the remodeling of K+ channels in SR62, the
relationship to and cellular regulatory effects of Ca2+ , [Ca]i , ryanodine receptor
(RyR), SERC, SR and Incx , and the excitation contraction (EC) phenomenon
associated with them57,59,60,61,69.
Several other concepts were considered or reviewed for input to the human
atrial tissue model. These included the Lou-Rudy dynamic (LRd)11,64,65 for initial
concepts and Markov element construction, the bidomain13 model for 3D
representation, the simple, 3D right atrium model22 that computes at near
physiological speeds, meshing 3D models48 and for a more complex cardiac
representation, the O’Hara Rudy dynamic (ORy) human ventricular model75.
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2.2 Critical Tissue Model Ionic Parameters
The critical ionic parameters to be modified are based from literature and

Table 1. Model Atrial Fibrillation Factors
Model Atrial Fibrillation Factors 23
Adjustments to SR for AF
Ca and Na Handling

Ionic Currents

INa
INaL
IKs

-10% peak density
Added Late Component
Increased 2-fold

IKr

Unchanged

IKur
IKi
Ito

-45% in the LA
Upregulated +100%
Itof -45%

ICaL
INcx
SERCA
RyR
SR Ca2+ leak
Tnl
INak

Current density is reduced by 50% in
AF. No Changes in voltage dependence
of activation and inactivation
Upregulated in AF (+40%)
Reduced maximal pump rate
Increased sensitivey for luminal Ca2+ (2
fold)
Increased by 25%
Unchanged
Unchanged

complement the existing modeling to date (Table 1). The nature of AF suggests a
methodical approach to variation of parameters Iks, Itof, Ikur, and
Ikr5,6,9,12,14,16,33,39,51, would be altered through the Nernst equilibrium, conductance
values, pump rates, concentrations, and/or buffers while Ikr would be altered
through gap junction densities. For AF detection purposes in this study, the
Grandi et al.23 parameters are used to define AF. The ionic kinetics of the model,
along with accompanying changes in association/disassociation and equilibrium
constants, are structured for modification in the manner represented in literature.
Other key19,24,49,51,67,70,71 ionic factors and their cellular AP impact, such as
calcium concentration [Ca2+]i, calcium current ICa, calcium markov gates, and
acetylcholine potassium IKACh are included to provide complete atrial
representation and are analyzed as appropriate for this study (Fig. 2).
10

The models assume cellular and tissue dimensions from the literature12,23
which are single strand tissue of approximately 1 cm in length and 0.0011 cm
diameter. Initial values for model parameters utilized were those published in
literature or made available with the models.
The tissue model is structured in a manner that allows for investigation of
numerous combinations of ionic states and flows as well as cellular and tissue
conditions. Fig. 4 provides a flow chart of the model construction and workflow.
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Grandi et al.
t0 alternan

23

Grandi et al. 23
Cell Model
Constants

Grandi et al. 23
Cell Model less
ODE15S Solver

Livshitz et al. 12
Ventricle PDEPE
Model Structure
Less Cell,
Constants and t0
alternans

X and Y
Hypothesis
Variable Table

Human Atrial
Tissue Model

MATLAB Solution
File

Ionic Current
Solution

Analytics
Reporting

Propagation
Analytics

Summary and
Conclusion
Analytics/
Reporting
Fig. 4 The modeling architecture used in the tissue study.
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2.3 Model Input Variables
The input variables were structured to represent the previously mentioned
elements of ionic channel state, tissue heterogeneity, and anisotropic
propagation etc. (Table 2). For cell length and radius, model mathematical

Table 2. Input Variables
Variable

Base State

Cell Length
SR
Cell Radius
SR
Diffusion Coefficient (E-4)
SR
Graduated AF Protocol
SR
Graduated AF Early
SR
Split Tissue Diff Coef (E-4)
SR - AF
AVE0118
AF
AVE0118
SR
Acetylcholine
SR
Junctional Volume
SR
Intracellaur Diffusion
SR
Diffusion Coef Ca + Junctional to Sarcolemma
Diffusion Coef Ca + Sarcolemma to Cyto
Diffusion Coef Na Junctional to Sarcolemma
Diffusion Coef Na Sarcolemma to Cyto

Variable values

UOM

75
90
100
150
200
8.200
8.713
10.250
12.300
13.325
35
70
120
175
275
0
0.25
0.5
0.75
1
0
0.0625
0.125
0.1875
0.25
35 SR
70 - 35
35 - 07
70 - 07
0
1
10
30
100
0
1
10
30
100
0
0.001
0.010
0.100
1
1.7790E-14 4.4476E-14 8.8952E-14 1.3343E-13 1.7790E-13

µm
µm

1.6400E-07
1.2200E-07
1.0900E-06
1.7900E-06
0.1X

8.2000E-07
6.1000E-07
5.4500E-06
8.9500E-06
0.5X

1.6400E-06
1.2200E-06
1.0900E-05
1.7900E-05
Base

8.2000E-06
6.1000E-06
5.4500E-05
8.9500E-05
5X

1.6400E-05
1.2200E-05
1.0900E-04
1.7900E-04
10X

µM
µM
µM
L
cm^2/sec
cm^2/sec
cm^2/sec
cm^2/sec

SR state of variable

limitations naturally set range limits (points of singularity, imaginary number
outputs etc.).
Model states to simulate sinus rhythm (SR) and atrial fibrillation (AF) were
taken from Grandi et al.23 and served as the analysis baseline for model outputs
used for AF detection. A unique and key aspect of this human atrial tissue strand
study was the method of model construction that allowed for progression of the
model from SR state to AF state through incremental changes in application of
the Grandi et al.23 AF factors. An arbitrary scale, as shown in Table 3 was
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selected that subdivided in a linear manner the progression of the AF factor

Table 3. Code Fibrillation Factors
Code Fribillation Factor Table
Tissue
Fibrillation
Chart
State
Factor
Axes
SR
0.00
SR
25% AF
0.25
.25AF
50% AF
0.50
.50AF
75% AF
0.75
.75AF
AF
1.00
AF

application into 5 steps from 0 = SR state to 1 = AF state. The model displays a
nonlinear response in the output variables that was consistent across outputs
and in key output variables provided early AF detection opportunities because of
the fast response to the linear changes in input. The nonlinear response of ionic
channels to regulation inputs, remodeling and other challenges is documented in
AF literature51.
Model states 0-SR through 1-AF were varied sequentially as a unique
modeling event to evaluate the potential AF detection at each AF level – 0, .25,
.50, .75, and 1.This progression in 5 steps as identified in the table is referred to
as “graduated AF” in the remainder of this report. The “graduated AF” approach
is utilized as the baseline AF development progression against which all other
study variations are compared. Because of the 5 step progression from SR to AF
all variable inputs are introduced to the tissue model in 5 increments to allow for
comparison of output characteristics that follow in the results section. Additionally
other non-ionic variable changes were usually compared to an SR baseline.
14

2.4 Model Output Variables
Table 4 shows the atrial tissue model wave characterization output factors.
The model output variables were drawn from literature and used to assess AF.
All output variables were analyzed directly in MATLAB. Output across the
variables proved to be consistent within a sub project group. Some of the output
phenomenon is due to the dependent nature of the variables created by the
model. Therefore because the model was consistent, beyond the model
validation discussion, not all variables are included in the discussion. Because
the model used a fixed basic cell cycle time, pacing at various Hz is not done.
Future versions of the model may be designed with this feature.
From Table 4, all output definitions are applied to all tissue elements and
reported for the 4th basic cycle length (BCL) or pulse. Pulse 4 was chosen in
order to avoid edge effects in both time and distance, pulse 1 was avoided due to
stimulus artifacts. The mean of an output variable value was calculated within
each BCL and then averaged across all cells (distance x). The non-refractory
tissue is defined as that tissue where the membrane potential is less than 10% of

15

Table 4. Atrial Tissue Wave Characterization Output Factors

Atrial Tissue Wave Charaterization Output Factors
Parameter

Definition
UOM
% tissue in non-refractory period for each pulse and
Refractory
distance x
%
APD
Action potential duration for each pulse and distance x
mS
Timing of maximum membrane potential for each pulse
MaxTMP
and x
mS
Timing of minimum membrane potential for each pulse
MinTMP
and distance x
mS
Timing of maximum membrane potential change for each
MaxDeltaTMP pulse and distance x
mS
Range of maximum to minimum membrane potential in
RangeTMP
mS for each pulse and distance x
mV
maximum membrane potential for each pulse and
MaximumAP
distance x
mV
minimum membrane potential for each pulse and
MinimumAP
distance x
mV
maximum membrane potential change for each pulse
and distance x - calculated to represent action potential
ChangeTMP
up stroke velocity
mV/ms
Prop Velocity Propagation velocity across entire tissue distance
µm/ms
Visual
Visual inspection of membrane potential surface plot

the maximum action potential voltage. The value of 10% was chosen consistent
with methodologies within or implied in the literature reviewed2,11,18,20,33,40,62,73.
APD is defined as the duration that the AP is greater than 10% of maximum
AP voltage.
MaxTMP is the mean time of the maximum membrane potential value.
MinTMP is the mean time of the minimum membrane potential value and
provides the timing of the AP upstroke.
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MaxDeltaTMP is the mean time of the maximum membrane potential change
and provides a measure of changes in propagation variability along the tissue
strand.
RangeTMP is the mean of the absolute difference between the maximum
and minimum of the AP and represents the mean AP peak height.
MaximumAP is the mean maximum membrane potential value.
MinimumAP is the mean minimum membrane potential value, within a BCL,
for each t series across all x and provides the value of the low side of the AP.
ChangeTMP is the mean maximum membrane potential change and
provides the maximum AP upstroke velocity in mV/ms.
Prop Velocity is the change in time, within a BCL, of the maximum AP
upstroke value from x = 1 to x = 100 (or cell 1 to cell 100) for pulse 4 and referred
to as propagation velocity. Propagation velocity is not a mean value.
2.5 Model Mathematics
The mathematical basis for the propagation model comes from Livshitz et
al.12 and was designed based on utilization of the MATLAB PDEPE solver.
MATLAB PDEPE program equation in generic form is
𝜕𝑣

𝜕

𝜕𝑣

𝜕𝑣

𝑐 (𝑥, 𝑡, 𝑣, 𝜕𝑥) = 𝑥 −𝑚 𝜕𝑥 (𝑥 𝑚 𝑓 (𝑥, 𝑡, 𝑣, 𝜕𝑥)) + 𝑠 (𝑥, 𝑡, 𝑣 𝜕𝑥).

(1)

Where x is distance, t is time, v is voltage, c is a function of x, t and v, m is the
problem type whose value is 0 for slab in this model, and s is a function of x, t
and v which is the membrane potential equation in this model. Axial current flow
which correlates to the diffusion coefficient below is
𝜕𝑣

𝑓 (𝑥, 𝑡, 𝑣, 𝜕𝑥) = −𝜆2

𝜕𝑉(𝑥,𝑡)
𝜕𝑥
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(2)

where 𝜆 is resistance. Cell model in generic form modified with the kinetics from
Grandi et al.23 model is
𝜕𝑣

𝑠 (𝑥, 𝑡, 𝑣 𝜕𝑥) = 𝐺 ∑ 𝑖𝑜𝑛𝑖𝑐 𝑐𝑢𝑟𝑟𝑒𝑛𝑡𝑠.

(3)

where 𝑠 is the membrane potential function and 𝐺 is the membrane conductance.
Initial conditions taken from Grandi et al.23 are
𝑉(𝑡𝑜 , 𝑥) = 𝑡𝑜 (𝑥).

(4)

where V is the definition of membrane voltage. Boundary conditions derived from
Livshitz et al.12 are
𝜕𝑣

𝑝(𝑡, 𝑥, 𝑣) + 𝑞(𝑡, 𝑥)𝑓 (𝑡, 𝑥, 𝑣, 𝜕𝑥) = 0.

(5)

where p and q are functions of t, x, and v that define the boundary values.
Livshitz et al.12 model cable equations are
𝑖 ′ sim + 𝐷

𝜕2𝑣m(𝑥,𝑡)
𝜕2 𝑥

= 𝑖 ′ ion +

𝜕𝑣m(𝑥,𝑡)
𝜕𝑡

.

(6)

where 𝑖 ′ sim is the stimulus, 𝑖 ′ ion is the transmembrane ionic currents and D is the
diffusion value. Livshitz et al.12 diffusion factor (D) for axial current (resistance
and conductance) are
𝑟

1

1

𝑚
𝜆2 = (𝑟 +𝑟
) = 𝐷 = 1/(𝜎 + 𝜎 )/𝑐m.
𝑖

𝑜

a

g

(7)

where 𝑟𝑚 is membrane resistance , 𝑟𝑖 is intracellular resistance, 𝑟𝑜 is extracellular
resistance , 𝜎a is the intracellular conductance per unit cable length , 𝜎g is
extracellular conductance per unit cable length , and 𝑐m is capacitance per unit
cable length. Livshitz et al.12 gap junction and cell size impacts with a = radius, 𝜎 a
= intracellular conductance, 𝜎g = extracellular conductance, and 𝜎g calculated are
𝜎a=σmyo*(𝜋)*a2
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(8)

𝑐m = 𝐶sc ∗ 2(𝜋) ∗ 𝑎 .

(9)

where σmyo is mycoplasma specific conductivity and 𝐶sc is cell surface
conductivity. Huxley-Hodgkin5 form of the action potential and ionic currents of
which a modified version was used by Grandi et al.23 in the model kinetics is
Cm

dV
  g Na V  VNa   g K V  VK   g L V  VL   I app .
dt

(10)

In Fig. 4, for the human atrial tissue model a mesh time Δt and mesh
distance Δx was determined from literature4,5,12,14,23,26,28 and an initial conditions
t0 as described later was input to the MATLAB PDEPE partial differential
equation solver. The PDEPE called the human atrial cell model function and
solved for dV/dt for the time mesh, then called the diffusion coefficient D function,
and calculated downstream membrane potential diffusion. The PDEPE then
incremented the Δx and iteratively solved for dV/dt in the time mesh and diffusion
factor across each increment of the x.
The model “pulsed” or extended simulation in time by another basic cycle
length (BCL) by taking the final time solution for all x from the first solution set,
and reinserting final time solution values as a new initial condition t0 for the next
time and distance mesh. The pulse iteration is called by code that encompasses
the PDEPE solver, and the pulse solution sets are merged to form the continuous
solution output and membrane potential plots.
The mathematics that drove the model size were the time (t, 600 ms) which
equated to the BCL, the total distance (x,100 cells) in tissue length, and the
number of pulses (N repeats of BCL). The time mesh and distance mesh
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remained the same throughout the model study iterations unless otherwise
noted.
2.6 Model Build Approach
The approach to building the model architecture, illustrated in Fig. 4, evolved
from research of existing cellular and tissue model concepts such as the Livshitz
et al.12and Grandi et al.23 models. The original Livshitz et al.12 model was
downloaded in MATLAB code from the Rudy Laboratory at Washington
University, St Louis. The original Grandi et al.23 model was downloaded in
MATLAB code from the University of California Davis Pharmacology labs
program.
The code for this study was derived from significant modifications and
concept utilization of the Livshitz et al.12, Grandi et al.23,26,28 , and various Rudy
models14,34,39,64,65,83. In addition, concepts were drawn from models in
literature1,2,3,4,7,13,15,18,20,27,36 . Code for activating the Markov model was taken
from literature11, 23, 52. Code for the AVE0118 and acetylcholine challenges was
based mathematical formulas derived from literature review 23,40,41,78,79,80,81,82,83
and inserted in the model as appropriate for hypothesis testing.
The initial conditions t0 for this study were derived from the cell model initial
conditions contained in the Grandi et al.23 MATLAB download code. Those initial
conditions t0 were restated into the format utilized by the Livshitz et al.12 model –
primarily by constructing repetitive t0 data for each Δx increment step of the
distance mesh representing the tissue strand in this study. The initial conditions
are scaled to the width x of the tissue as needed. When new variables were
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introduced to the model differential equation initial values were drawn from
literature. The methodology offers a convenient method for insertion of human
physiological data if available as well as provided a clean starting point transition
from a cell model to a tissue model.
The Livshitz et al.12 model concepts and template provided critical methods
for construction of the model execution file, the PDEPE approach, model
constants integration through the various MATLAB workspaces and the biphasic
stimulation approach which in total pulse summed to zero but provided for the
effects of upstream gain and downstream loss of charge through the tissue. The
Livshitz et al.12 model also provided the boundary conditions, which were
introduced as 0 and the initial diffusion factor. The Grandi et al.23 model provided
the human atrial cell kinetics concepts, model constants and as indicated, the
initial conditions. The Iks and Ca Markov code and the Ca SR release flux
mechanism code are some of the most critical and complex in the model and
therefore used as is from Grandi et al.23. The same 5 basic model MATLAB code
files, the model execution program, the PDEPE program, the human cell kinetics
program, the model constants file and initial conditions file provided the model
platform for study iterations and discussions that follow.
The initial model was constructed in size based on the Livshitz et al.12 model
– (4 pulses, 400 ms (BCL) and 50 cells). Each cell is .01 cm long and therefore
the model represents, at the x mesh used, .5 cm of tissue. The model was
initiated at 400 ms but required reconfiguration to 500 ms BCL with all other
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Grandi et al.23 model constants, initial conditions and cell kinetics maintained.
The model runs in this mode in approximately 20 minutes.
The model was then successfully run as per above, but extended to 8 pulses,
i.e. extension in time, and at 50 cells wide. The model output stabilized at 8
pulses with a diffusion coefficient of .0035 (versus the initial Livshitz et al.12 value
of .0007). The diffusion coefficient value was derived through substitution of
known human atrial values in the Livshitz et al.12 diffusion coefficient equation
and confirmed for all x by consistent peak membrane potential across the pulse.
The model was then expanded to 8 pulses and 100 cells wide to provide both
time and distance parameters without edge effects. The initial conditions file t0
again was created from the Grandi, et al.23 model but replicated by an identical
100 to match the model cellular structure. The BCL was increased to 600 ms to
account for the forward propagation wave movement across 100 cells in 8
pulses. This is the model configuration used for discussion outputs in the study.
The model runs in approximately 3 hours.
The analytics code was established as arrays of solution data that
collectively represented the model solution output and membrane potential plot.
The final state was chosen, to provide significant tissue area in which analysis
could be completed yet balance the significant amount of data (500 MB) each
iteration created. A 32 pulse 100 cell 700 BCL model was used for successful
model validation with a run time in excess of 8 hours.
2.7 Atrial Fibrillation Detection
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The intent of this study is to provide a tool for potential early AF detection.
From the earlier discussions on AF background and literature review, P waves
from the ECG and other signal methods are often used for arrhythmia detection
and management including AF17. Potential signal detection/prediction algorithms
include mean atrial rate, rate and count, ‘X out of Y’, beat –to-beat and combined
algorithms17. In addition, AP propagation safety factor, curve fitting, specific
integration and slope analysis have been used in efforts towards AF identification
and analysis14.
The intent of the signal analysis is to provide a degree of correlation with
diagnosis from more conventional ECG. Research on AF has stimulated the
development of a wide range of signal processing tools to better understand the
mechanisms of AF initiation, maintenance and termination. For example, the
wave length concept has been presented as a potential model of AF activation.
The average size of reentry pathways during AF is dependent of atrial
wavelength defined by the product of conduction velocity and refractory period,
i.e. the time that the atrial tissue is not excitable. Longer wavelengths are
associated with larger and few wave fronts, while short wave lengths result in a
large number of smaller circuits which may have implications for arrhythmia
susceptibility and stability17. With the aim of aiding early AF detection and an eye
towards future provision of physiological meaningful inputs, specifically current or
flux into a more advanced volume AF models, the input and output variables
were identified that provided physiologically relevant balance of atrial scenarios
and wave factors that the model could support. Additionally with earlier detection
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of atrial fibrillation f-waves, a feedback scheme for wave correction could be
developed to provide a further model of initiation, detection, and correction.
Most standards of change defining AF were developed after AF had been
diagnosed. The change standard threshold defined by the study output variables
below are intended for use prior to AF diagnosis. In order to extend a detection
concept the model was run in SR state, then in AF state as defined by the model
variable change in Table 2 and Table 3. The variables that were measured, as
the model outputs, are shown in Table 4. The results were reviewed for
significance, a percentage change of 25% in propagation velocity was arbitrarily,
but not unreasonably17,34 assumed detectable by electrocardiographic imaging
methods. Detection of the change in APD and other model output elements of
the heart wave model are challenged by current technology. The development of
advanced electrodes, such as the ablation probes and flexible micro electrodes
offers encouragement that the detection technology progression will continue. In
preliminary simulations wave propagation exceeded 50% reduction, approaching
a 61% reduction for propagation velocity. On the other hand, APD decreased
12%. Based on the initial propagation findings, the 10 parameters identified in the
study (Table 4), were determined from literature17,32 to be an acceptable method
of wave analysis for AF.
2.8 Modeling Approach
The study was organized around 9 subprojects as shown in Table 5. Project
elements were intended to study the ability for AF detection under varying ionic
and physical property conditions. Subprojects SR and AF Baseline, and Model

24

Validation were used to validate the model. The references shown in the table
sections drove the ideation but not necessarily the parameter value selection
which is discussed in the sections that follow.
The variables that were modified as inputs and values used are shown in
Table 2. Not all variables show linkage to references. Where, based on the
uniqueness of the model, and if variable values where not published, the
variables were varied around the base state SR conditions unless otherwise
noted in the sections below. There were additional iterations of the modeling that
providing no further information or guidance to further analysis. Those additional
iterations are not reported here but include concepts such as stimulus variation.

Table 5. Tissue Model Study Project Elements.
Element
Model Validation

Baseline
Studies as indicated

Adjustments
10 Factors including
potassium, AVE0118,
and Acetylcholine
challenge

Model Baseline – SR

Sinus Rhythm

Graduated AF,
Reference Table 3 Code

and AF12,14,23,26,28

Fibrillation Factors and,
Table 2 Model Atrial
Fibrillation Factors
Early AF

Table 3 Code – 1st Two

Graduated AF

Steps in AF Progression
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Table 5. Tissue Model Study Project Elements Cont’d.
Element
*External Cell

Baseline
Graduated AF

External Cell Radius

Geometry12,14,23,26,28
Split Tissue

External Cell Length
1st ½ Tissue SR

Graduated AF

Condition45,72
*External Diffusion

2nd ½ Tissue AF
Graduated AF

External Cell Model

Coefficient12,14,23,26,28
Isolated K+ and Na+,

Adjustments

Diffusion Factor
Graduated AF

K Adjustments Alone

Ca2+ Ionic

Na-Ca Adjustments

Impacts12,14,23,26,28

Alone

*Internal Cell

Graduated AF

Sarcolemma to
Junctional Space

Conditions12,14,23,26,28

Diffusion
Junctional Volume Ratio
to Total Cell Volume
Β Adrenergic

Graduated AF

ISO Factors

Challenge23,87
*Results Shown in Appendices

2.9 Baseline Construction
The process to construct the comparisons to baseline values was: first) set
the input variable through the constants file and run the model to generate an
iteration solution set – generally the model state was SR in order to see if the
input variable change altered the SR state relative to AF, second) through the
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analytics program calculate the currents and non-solution variables within each
BCL of the solution set, third) through additional analytics programs calculate the
output variables data for each BCL for every t column across all x of the solution
set, fourth) in the analytics program calculate the value for all BCL for each
particular output variable in the solution set, and finally, fifth) overlay selected
output variables against the corresponding baseline data in chart and table form.
For each scenario (for example external cell geometry) a consolidated data
set was created as in Appendix F, A Scenario Model Iteration Data Set. From the
model iteration data set a particular output variable was selected for comparison
to the baseline data for that output variable as shown in Appendix F, A Scenario
Variable Comparison to Baseline. Note all scenarios are 5 iterations of the model
reflecting the SR to AF progression scheme. Beyond baseline some scenarios
are iterations of the SR to AF progression with a frozen fixed input variable value
such as potassium values, while others, as illustrated in Appendix F, A Variable
Scenario Model Iteration Data Set, and A Scenario Output Variable Comparison
to Baseline, involved the model locked in a fixed state, generally SR, and the
input variable incremented/decremented with each of the scenarios 5 model
iterations. An iteration resulted in 5 data arrays of 9600 X 100 X 102 data
elements in size.
The outcomes for propagation velocity, shown in Table 6, detailed by the
input varaible, for the various senerios are shown by iteration of the model. If the
measureable change in propagation velocity is greater than 25% from the SR
baseline then the senario is considered successful in potentially predicting an AF
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outcome. The model baseline for AF development, is defined as the model with
all variables held constant, except for the Grandi et al.23 changes identified in
Table 1, which were incremented per the schedule of Table 3. Graphic output of
the baseline model is shown in each section. The baseline scenerio of the model,
as defined and shown in row 1, Table 6, was greater than 25% and therefore the
model is considered successful as a potential predictor of AF as defined by the
changes defined by Grandi et al.23.
2.10 Computation Equipment
The model was designed and run on standalone PCs utilizing both Microsoft
Windows versions 7 and 8.1 with MATLAB versions R2011b, R2013b and
R2014a. All results presented in this report are from the MATLAB R2014a
version run with Microsoft Windows 8.1 on PC platform.
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Chapter 3 Results
3.1 Model Validation
To provide a logical validation method, considering the tissue model was
derived from several model concepts, 10 elements were addressed – APD, mean
maximum membrane potential change, calcium concentration, Ca2+ SR flux
release, calcium currents, acetylcholine challenge, AVE0118 challenge, a steady
state challenge as per Livshitz et al.12, and later in discussion sections an IKs
Markov model and the elements of the potassium current. Calcium ionic currents
and concentrations, key to excitation contraction coupling, are included here for
proper diligence to that element of the physiology. Because of the model
differences with those in literature, directional trends, such increasing or
decreasing potential and or concentration levels, are sometimes discussed.

A

B

Fig. 5 Model baseline and validation (A) APD, (B) mean maximum membrane
potential change.

In Fig. 5A, APD decreased as predicted23 from 515 ms in SR to slightly less
than 455 ms in full AF conditions. This is consistent with the cellular model
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concepts upon which the tissue model is based. The decline in APD was
nonlinear across the early SR – AF spectrum suggesting potential exists for early
detection use.
In Fig. 5B, mean maximum membrane potential change increased as
predicted23, in the model, from 14 mV/ms to 22 mV/ms through the SR to AF
spectrum and is consistent with the concepts upon which the tissue model is
based. The non-linearity of the early change in upstroke velocity was more than
that of the APD and of potential predictive use.
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Fig. 6A and 6B are from literature describing the Markov model used to
emulate the Ca SR release and Fig. 6C and 6D are outputs from the model. For
clarification of SR notation the model outputs are calcium sarcoplasmic reticulum
(SR) release, and the figure notation references SR - sarcoplasmic reticulum as
well as the model state is sinus rhythm SR. The Markov Ca SR release gate

A

B
KI - RyR Ca-dependent inactivation rate
KIM - RyR re-priming rate
KO - RyR Ca-activation rate
KOM - RyR deactivation rate
O - Open State
I – Inactivated State
R – Resting State
RI – Resting Inactivated

C

D

Fig. 6 Ca SR release kinetics for the tissue model (A) Markov model for Ca
release28, (B) Markov model variables28,86 , (C) Ca SR release Markov gates,
(D) Ca SR release activity profile. The Ca release flux mirrors the Markov gate
states in form and timing of peak.
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profiles (Fig. 6C) match literature28 with rapid opening, inactivation and then
gradual transition to resting state. The model also produced the Ca SR release
flux (Fig. 6D) as expected.
In Fig. 7A, the calcium concentration measured in the fourth pulse in the 25th
tissue strand decreased as predicted23, in the model from steady state of 2.5 mM
to just under 1 mM and this matches literature8,12,14. In Fig. 7B, the peak calcium
current was expressed 50 ms earlier and at 1.5 mV higher amplitude in the AF
AP cycle than the SR AP cycle. Steady state calcium currents were similar

A

B

Fig. 7 Model validation for calcium (A) [Ca]i Concentration, (B) calcium
currents.
between AF and SR with AF 0.1 mV below SR. This is attributed to the calcium
buffers and is consistent with literature23,26.
For the acetylcholine (ACh) challenge (Fig. 8A), code was constructed to
simulate the IKACh challenge similar to the Grandi et al.23 model. APD23,83
decreases with increasing ACh concentration as expected.
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A

C

B

D

Fig. 8 Model validation for acetylcholine and AVE0118, (A) APD –
Acetylcholine Challenge, (B) Y State Variable in AVE0118 challenge, (C) AF
membrane AP with AVE0118, (D) tissue AF AVE0118 impact on Ikur current.

The AVE0118 challenge is shown in Fig. 8C and 8D. AVE0118 blocks the Ikur
channels Kv1.5 and Kv1.382. Ikur channels are unique to the human atrial
chambers assisting in providing the sharp drop in AP form necessary for rapid
AP adaptation. AVE0118 does not adversely impact the human ventricles, thus
providing a potential arrhythmia drug for AF with no detrimental ventricle side
effects. As in the acetylcholine challenge, code was constructed for the AVE0118
simulation of IKur block similar to the Grandi et al.23 model. Simulation of IKur
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block82 was initiated with a voltage gating factor inserted in the model and an
initial condition of 0.01 for the state variable Y, in the PDEPE function, describing
the changes in the fraction of unblocked IKur channels as in literature78. As per
Fig. 8C and D, there was the expected change in AP form and duration in AF.
The impact on Ikur was significant and notably greater at smaller concentrations of
AVE0118 (Fig. 8D), suggesting, based on this model, that smaller dosages could
be used to achieve the same impact on AF then described in literature. In
addition to Ikur, AVE0118 is suggested79 to impact Ito and IKACh with IKur reduced
more in AF than SR79.
Whether inhibition of Ikur prolongs or shortens APD depends on the disease
status of the atria and is determined by the level of remodeling81. Literature
suggests the model should increase IKr and IKs - less in AF than SR; decrease
APD in SR but increase it in AF and decrease the AP plateau phase of the AP
wave form, which did occur, due to the impact of IKur. For the Y state variable in
the AVE0118 challenge (Fig. 8B), the initial condition for state variable Y was set
to 0.01 as a best estimate as no information was provided in literature. The Y
variable tracked similar to the Grandi et al.23 model except for what appears to be
potentially a difference in initial value, i.e. 0 for Grandi et al.23 model.
For action potential duration by pulse variation (Fig. 9), the steady state12,80
of the tissue model, was determined in a continuous run event of 32 pulses. The
APD varied +/- 1.25% between pulses and is one indicator of model stability. The
APD curves remained the same as the baseline used in the tissue model.

34

For computational purposes, previous studies have utilized a piecemeal
approach, starting and appending the model where the previous run stopped (i.e.
end of cycle). The study model was completed in a test scenario with the discrete
appends of 64 pulses, and the model displayed similar results to continuous
runs. For the study, all modeling runs were continuous events initiating and
completing each scenario data set.
The potassium currents, both with and without the Iks Markov model exhibit
the magnitude reflected in the cell model, provided consistent timing reflective of
the AP form as well as provide clear input on analysis of the gating factors
involved. In summary the validation along with the baseline results are
considered successful and provide support for use of the model in AF detection.

Fig. 9 Model validation for extended run APD by
pulse variation.

3.2 Model Baseline – SR and AF
The initial model baseline results were analyzed via membrane potential
plots with for SR and AF conditions (Fig.10). The membrane potential plots were
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reviewed for continuity of form and consistency within the BCL parameter of the
model run. As stated earlier, all model parameters remain the same except for
the model atrial fibrillation factors parameters identified in Table 1, that
differentiate SR from AF. The baseline is established by running 5 iterations of
the human atrial tissue model with all parameters held constant except for the
atrial fibrillation factor which is set to 0, 0.25, 0.5, 0.75, and 1 successively in
each iteration to create 5 output sets. Fig. 11A shows the maximum membrane
potential computed for every BCL and model iteration. Fig. 11B – 11F represents
the discrete model iterations from SR through AF (graduated AF) on the
horizontal axis, and the output for each iteration on the vertical axis. Each line
chart in Fig. 11B-11F is a mean output measured across the tissue strand for
each BCL, except for propagation velocity (Fig. 11D). As can be observed in Fig.
11, 12, and 13 there is consistency in the directional movement of the model
output measures, increasing or decreasing, as the model iterates across the SR
to AF scale. Based on model validation and consistency of output, only the mean
APD, mean propagation velocity, non-refractory time, mean AP upstroke velocity,
and mean timing of maximum membrane potential change will be discussed. For
model projects, input parameters were modified systematically as detailed in
Tables 2 and 3 and compared to the baseline for each iteration (graduated AF) to
determine if the variable was driving the model similar to AF conditions. The
baseline SR and AF are shown in Table 6. For the model projects, if the change
in the scenario propagation velocity is greater than 25% from the SR baseline,
then the scenario is considered a potential predictor of AF.
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A

B

Fig. 10 Tissue Model Membrane Plot of (A) SR and (B) AF.
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A

B

C

D

E

F

Fig. 11 Model output variables for baseline comparison (A) maximum
membrane potential by tissue state, (B) APD, (C) mean range of AP, (D)
propagation velocity, (E) mean timing of maximum membrane potential, (F)
mean non refractory time.
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Fig. 12 A and B represent mean maximum membrane change and mean
A

B

Fig. 12 Model output variables for baseline comparison, cont’d. (A) mean
maximum membrane change, (B) mean minimum membrane potential.

minimum membrane potential which are consistent with expected AF behavior.
Fig. 13 is mean timing in ms of minimum membrane potential and it is consistent

Fig. 13 Mean timing in ms of minimum
membrane potential.

with AF behavior expectations. Fig. 12 and 13 illustrate details of the increased
peak AP potential and decreased minimum AP potential as AF developed in the
model.
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Table 6. Propagation Outcomes (see footnotes below)
Propagation Outcomes um/ms
SR - State - Baseline
9.2
9.2
9.2
Graduated AF Factor
0
0.25
0.50
Senario Iteration
1
2
3
Modeling Senario
2
1 Graduated AF
9.2
6.12
4.66
Cum Reduction
0
33%
49%
1

+

2 AF W/o_K adjustment

3

7.68
17%

6.94
25%

9.2
0

6.3
32%

4.79
48%

3.99
57%

3.52
62%

5

9.2
0

6.11
34%

6.24
32%

5.96
35%

-

1,6

9.2
0

8.91
3%

9.12
1%

8.86
4%

-

1,7

10.36
-13%

9.54
-4%

9.2
0%

8.74
5%

9.23
0%

1,8

11.23
-22%

10.57
-15%

9.2
0%

8.72
5%

8.85
4%

9.2
0

8.78
5%

8.1
12%

7.58
18%

7.53
18%

9.2
0

8.2
11%

7.37
20%

6.68
27%

6.12
33%

9.2
0

9.21
0%

9.22
0%

9.23
0%

9.24
0%

9.2
0

9.2
0

9.2
0

9.2
0

9.2
0

9.17
0%

6.1
34%

4.66
49%

3.95
57%

3.58
61%

9.2
0

9.08
1%

4.17
55%

2.36
74%

2.36
74%

3.58
61%

3.58
61%

3.58
61%

3.58
61%

3.58
61%

9.17
0%

9.19
0%

9.2
0%

9.2
0%

9.2
0%

9.2

6.9

5.17

4.04

3.35

0%

25%

44%

56%

64%

2+

4 SR to AF Tissue Split

4

Cum Reduction
Cum Reduction
6 Cell Length Variation

Cum Reduction
7 Cell Radius Variation

Cum Reduction
1

Cum Reduction
9 Graduated AF Early

Cum Reduction
10 Junctional Volume Variation

Cum Reduction
11 Intracellular Diffusion

1

Cum Reduction
12 Iks Markov Implemented

Cum Reduction
13 Acetylcholine Block

1

Cum Reduction
14 AVE0118 AF Block

Cum Reduction
15 AVE0118 SR Block

1

Cum Reduction
16 β Adrenergic Challenge

Cum Reduction

3.58
61%

8.43
8%

Cum Reduction

8 External Diffusion

3.95
57%

8.93
3%

3 AF W/o_Na and Ca adj

5 SR to SR Tissue Split

9.2
1
5

9.2
0

Cum Reduction
+

9.2
0.75
4

1

1
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Table 6 Footnotes
1 - All iterations run in SR state; 2 - baseline for AF detection comparisons created
by implementation of Graduated AF Factors; 3 - K+ AF factors removed; 4 – Na+ and
Ca2+ factors removed; 5 - AF factors implemented at tissue strip midpoint; 6 scenario measured on iteration 4, iteration 5 illustrative only; 7 - midpoint of range
variation is SR norm meaning the midpoint value is the SR norm for the model; 8 midpoint of range variation is SR norm

3.3 Early AF
The early AF element of the study compared the model output through the
implementation of the AF parameters implemented in Table 2 from SR through
the first two steps of code fibrillation factors in Table 3 to represent 25% of the
AF adjustments. The cumulative impact of the first two steps of Table 3 are
defined as early AF for this study. The results are illustrated in Fig. 14A through
14E. The intent was to review the models ability to determine, based on the
definition of early AF, 25% change in APD, wave propagation velocity and timing
of maximum AP potential. The model potassium currents, model state variables,
the INaK pump current, the Incx exchanger current, and ICLCFTR calcium dependent
chloride current all contribute to the model nonlinear response to the mean timing
of the maximum AP potential and propagation velocity. The calcium currents and
concentrations as expected, showed no unusual activity in the early AF model
run results. This provides a logical basis for the non-linear response observed in
the first step (.25AF) of the model AF progression. In all parameters and in
particular wave propagation velocity, the early AF model outputs followed the
form of the full AF model run output and the final values matching the 25% AF
value of the full AF model run. Wave propagation velocity in row 9, Table 6, and
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the mean timing of the maximum AP potential were nonlinear in the model output
during the first 25% of AF onset, reducing 3 of 5.6 um/ms and 90 of 160 ms
during this period, a change greater than the 25% threshold, thereby providing a
potential detection key in the effort to detect the early onset of AF. While the
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A

B

C

D

E

Fig. 14 Early AF detection modeling scenario outputs, (A) early AF APD, (B)
early AF mean membrane potential change, (C) early AF mean non refractory
Time %, (D) early AF propagation velocity, (E) early AF mean timing of
maximum membrane potential change.

other parameters were more linear in change, it does indicate that wave analysis
43

based on full model AF output including mean timing of the maximum AP
potential and wave propagation velocity, will be a potential but challenging,
based on normal atrial variability, to detect early AF.
3.4 Split Tissue Condition
Cardiac tissue, including the atrium, displays inhomogeneity in structure and
microstructures56 that are believed to contribute to AF14,31,36. The model was able
to support split modes – specifically the concept of initiating the model in either
SR or AF mode and then at a prescribed time or distance change to a different
mode such as from SR to AF or a gradient of AF. Achieving the split tissue
condition modeling involved splitting the mesh into separate sections via the
PDEPE function with an “if x > * value” statement and if true then updated model

Table 7. Split Tissue Variation Values
Split Tissue Variation Table
Tissue State Step
SR - SR
SR - AF
Iteration
Diffusion Variable Step
1
0.0035
0.0035
2
0.0035 - 0.0007 0.0035 - 0.0007
3
0.0070 - 0.0035 0.0070 - 0.0035
4
0.0079 - 0.0007 0.0079 - 0.0007
5
-

constants were inserted into the PDEPE workspace through the global
“data.variable” for the duration of the pulse. The split tissue is additionally
intended to represent the phase singularities believed needed to initiate rotors 44.
The split tissue model involved two modes of tissue splitting with two significantly

44

different outcomes; first, SR tissue was split with different diffusion coefficient
values. The diffusion values were derived from analysis of the equations from the
Model Mathematics section 2.4 and arbitrarily set to represent non-homogeneous
tissue through distribution of gap junctions. The external diffusion coefficient was
modified to model a decrease in gap junction resistance as compared to SR. The
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Fig. 15 Modeling of tissue inhomogeneity output results (A) split tissue APD ,
(B) split tissue mean maximum membrane potential change, (C) split tissue
mean non refractory time %, (D) split tissue timing of maximum membrane
potential change, (E) split tissue propagation velocity.

underlying tissue remained SR state while, at cell 50, via the method described
above the diffusion coefficient was changed per Table 7. Second, model
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iterations were done with the tissue state changing as well from SR to AF along
with the change to the diffusion coefficient. In Fig. 15A through 15E, the curves
are labelled with the diffusion coefficient values as “from - to” .The split tissue
change in diffusion had relatively little impact, less than 25%, on the studied
wave variables (also confirmed Table 6, row 5). In Fig. 17A, which is SR state,
the impact of a 10X change in the diffusion coefficient can be seen on the
membrane potential plot in agreement with the small change observed in the
results discussed later in the section from standalone diffusion coefficient
variation. However the “mean” output measures in Fig. 15A through E disguised
the small impacts in diffusion coefficient change that the membrane potential
plots show in Fig. 17A. In Fig. 15A through 15E and Fig. 17B, which is AF state,
the additional change in tissue state from SR to AF brought wave form
characteristics in line with AF including greater than 25% change in propagation

Fig. 16 Split Tissue Maximum Membrane
Potential by Pulse
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velocity. Fig. 16 illustrates the PDEPE solver in estimating the step function. The

A

B

Fig. 17 Split tissue modeling membrane potential plot outputs (A) SR tissue
membrane potential plot with split diffusion coefficient .0070 to .0007, (B) split
tissue SR to AF membrane potential with split diffusion coefficient .0070 to
.0007.
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step function matched the graduated AF function for the base line modeling.
For a single step the model showed a dramatic demarcation resulting from
the step change. By natural extension of the differential in wave propagation
across the step boundary, the split mode modeling allows presentation of the
beginning of a potential AF wave front and discontinuous propagation14 modeling
upon which additional analysis of wave front angle could be measured to
correlate with rotor development14,31 .
3.5 Isolated K+ and Na+, Ca2+ Ionic Impacts
In Fig. 18A through 18E, the model was run with all variables and constants
set to SR state and the AF initiating conditions split into the K+ and Na+, Ca2+
components. Literature28,34,50,64,65,66,68 suggests that channel pathologies can and
do develop independent of each other and it could logically be concluded such
happens in early AF. The non K+ component change meant that IKs, Ikur, Iki, and Ito
remained unchanged; conversely the non Na-Ca change meant those K+
elements were the only changes. In Fig. 18A and 18C, the differing effects of
sodium, calcium and potassium are observed in parameters such as APD where
isolating the effects of each results in AF development curves with K+ impacting
early and Na+ and Ca2+ impacting later with an additive effect compared to the
baseline model. In Fig. 18B and 18D, the isolated effects have the appearance of
K+ effects, with K+ mirroring and matching the baseline AF development curve
suggesting singular K+ effects on developing AF. Na+ and Ca2+ effects are minor
on propagation velocity and mean timing of maximum membrane potential
change. As seen all potassium channels reflect faster K+ impacts (also discussed
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later in Fig. 29). The significance of these models’ results are that if early AF
conditions do in fact develop in isolated ionic channels, either in Na+ and Ca2+ or
K+ channels, then wave analysis, electrocardiographic imaging, or other methods
would potentially show results that may be indicative of potential developing AF
conditions. A limitation of this analysis is that Grandi et al.23 did not provide these
conditions as AF. The study is drawn from literature34, 50,55,58,64,68 and providing
this scenario as a potential hypothesis for future modeling, has clinical limitations.
All other model parameter outputs displayed similar results. It is a possibility that
an unbalanced ionic condition such as those modeled in this scenario could be a
driver of remodeling associated with early AF49,62 as well as be associated with
other pathologies.
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Fig. 18 Modeling variable outputs for the separation of Ionic effects (A) K+, NaCa impact APD, (B) K+, Na-Ca impact mean maximum membrane potential
change, (C) K+, Na-Ca impact mean non refractory time %, (D) K+, Na-Ca
impact propagation velocity, (E) K+, Na-Ca impact mean timing of maximum
membrane potential.
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3.6 β Adrenergic Challenge
Inherited gain-of-function mutations of genes coding for subunits of the heart
slow potassium (IKs) channel can cause familial AF88. A potentially prevalent
mechanism is that β-adrenergic receptor (β-AR)-mediated regulation of the IKs
channel, a natural gain-of-function pathway, can also lead to AF. Computational
modelling has revealed that β-AR stimulation-dependent accumulation of open
IKs channels accounts for the pro-arrhythmic substrate. Evidence exists that βAR-regulated IKs channels can play a role in AF and imply that specific IKs
deregulation, perhaps through disruption of the IKs macromolecular complex
necessary for β-AR-mediated IKs channel regulation, may be a novel therapeutic
strategy for treating this most common arrhythmia.
Isoproterenol (ISO) simulation of β -Adrenergic challenge PKA-specific
regulation of various targets was modeled as following23: IKs maximal
conductance was enhanced (3 fold) and the current-voltage relationship was leftshifted (by 40 mV); IKur maximal conductance was enhanced (3 fold)34; troponin I
affinity for Ca2+ was decreased (i.e., kd was increased by 50%); Ca2+-sensitivity
of SERCA was enhanced (i.e., the forward mode km was reduced by 50%); Ltype Ca2+ channels were increased (+50%) and channel availability was shifted
leftward (by 3 mV); RyR sensitivity for luminal Ca2+ was increased (2 fold); affinity
of Na+ pump for intracellular [Na+] was increased by 25%. The β-AR challenge
was implemented in a structure in the same manner as the AF state, therefore
allowing for a graduated implementation similar to Table 3. As in most of the
previous scenarios the β-AR model iterations were conducted on the SR state of
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the tissue model to isolate the effects of β-AR challenge. Fig. 19A and 19B, the
show that propagation velocity and mean timing of the AP potential maximum
were similar at end state (5 versus 6 um/ms and 165 versus 185 ms,
respectively).
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Fig. 19 β Adrenergic challenge results A) propagation velocity, B) nonrefractory period, C) maximum membrane potential change, D) mean APD,
E) mean timing of maximum membrane potential change.
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In Fig. 19B and 19D, the model non refractory period was more significant in
the ISO than was the change in APD, suggesting the threshold for AF was less
than the impact of the β-AR mediated regulation of IKs. Therefore, if the β-AR
impact is correct, then the gain of function impact in IKs surpasses the AF
threshold for impact, implying that during ISO challenge the β-AR is responsible
for AF. Fig. 19C illustrates, in the β-AR challenge model output, the mean
maximum membrane potential change matches in AF and ISO challenge. In row
16, Table 6, the β-AR challenge scenario changes propagation velocity by 64%
at AF end state and 25% in early AF than required. The conclusion drawn is that
the model is generally more sensitive to AF as defined by Grandi et al.23 to detect
AF as defined by the β-AR challenge and therefore the analysis is a potentially
useful tool in early AF modeling.
3.7 Potassium Ionic Flows and Markov Models
In all scenario simulations the potassium currents responded as generally
predicted in literature. The timing and content of the potassium response varied
as described below.
Ultra rapid activating potassium current Ikur,(down regulated 45% in AF) is
shown in Fig. 20A. As indicated in the earlier AVE0118 model validation
discussion the Ikur channels are unique to the atrial tissue and therefore offer
potential unique detection and mediation opportunities. The Ikur responded to the
Grandi et al.23 model AF adjustment as expected. Voltage activated gates, r –
activation and s – inactivation, indicates that the membrane potential increase in
AF increases the initial Ikur current through gate r, Fig. 20B to 20C, and s returns

55

to near normal state. The same membrane potential increase causes the
inactivation gate s to initiate and remain at higher activity levels, Fig. 20D to 20E,
therefore overriding the r activation impacts. The resulting Ikur current, Fig. 20A, is
significantly increased in the early AP form and then depressed with the
expected resulting higher and shorter AP form. The behavior of the Ikur channel
gates in this model are contributors to the nonlinear behavior of the wave forms
referenced earlier AF state discussions.
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Fig. 20 Ikur current analysis (A) Ikur current, (B) Ikur r activation gate in AF, (C)
Ikur r activation gate in SR, (D) Ikur s inactivation gate in AF, (E) Ikur s
inactivation gate in SR.
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Slowly activating potassium current IKs (up regulated 200% in AF) shown in
Fig. 21A through 21C – shows that the IKs current responded to the model AF
state with a significant nonlinear increase. The IKs is the principal repolarizing
current. The sharp nonlinear increase in IKs current in Fig. 21A, caused by the
upward shift of the activation gate x in Fig. 21B helps drive the shortened AP
form and consequential shortened APD. The equilibrium value for IKs current is

A

B

C

Fig. 21 IKs current analysis (A) slowly activating IKs current, (B) activation gate
x in AF, (C) activation gate x in SR.

58

driven by the intra cellular concentrations of K+ and Na+ and consequently further
impacted by the activity of the Incx pump in AF stimulation. The single activation
gate of the IKs model is also both time and voltage driven with heavier
dependence on voltage – i.e. voltage factor in the time constant calculation. The
activation gate x is squared in the current calculation, driving the nonlinear
response and also impacting rate adaption. The conductance is fixed in the
model but offers another opportunity for expression modeling. The genetic
linkage to AF is through the 4 α subunits KCNQ1 and 1 β subunit KCNE1. The
KCMQ1 IKs α-subunit mutant is associated with familial AF, and the LQT and
SQT syndromes53,54. The model results, the genetic linkage and known
pathologies, offer potential for the early AF detection. In the Markov model, the
IKs repolarization reserve can accommodate IKs impairment.
The IKs Markov model for polarization reserve, as illustrated in Fig. 22A,
functioned as expected when activated. The Markov transition factors β, η, δ, γ,
ψ, α, and θ along with the definition of zone 1, zone 2, and open states were
direct from literature23,27,34. The Markov gates, as shown in Fig. 22B functioned
as expected in the human atrial tissue model and as characterized in
literature11,27,34 with a rapid open state increase and then the zone 1 steady
increase referred to as the repolarization reserve. As seen in Fig. 22C, the
relative amplitude of the current, -.005 to +.035 µA mutes the effect on the
membrane potential, however the absolute AP form and position are impacted by
the models in these scenarios. The behavior IKs of is more accurately stated,
earlier repolarization activity through the reserve, with the Markov
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model11,26,27,28,34 and therefore more desirable. Note row 12 vs row 1, Table 6,
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E

Fig. 22 Modeling results for Markov IKs are consistent with literature (A) IKs
Markov Model34, (B) Markov gate profiles, (C) IKs currents w and W/o Markov
model at SR and AF, (D) Markov IKs APD, (E) Markov IKs propagation velocity.
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Fig. 22D and 22E show very modest changes that are small noting the mean
method of the value calculation for APD. Model constants within the Markov
model match the predecessor ventricular model28 and were modified, such as IKs
conductance, for atrial tissue through literature research.
Time independent potassium current Iki (up regulated 100% in AF), shown in
Fig. 23, indicates that the Iki current responded to the AF state with a sharp spike.
Iki channels close upon depolarization, slowing membrane repolarization and
helping maintain a more prolonged cardiac action potential – a key contributor to
the lower membrane resting potential in the model AF state. In the tissue model,
the Iki current moved forward approximately 200 ms in the action potential with
peak outflow 2x as per the AF factor maximum 1.0. The forward movement
helped shorted the APD. Iki is an inward rectifier channel that, by mediating a
small depolarizing K+ current at negative membrane potentials, helps establish
resting membrane potential. The up regulated Iki as expected, throughout the
propagation wave, drove the lower resting membrane potential in AF. As seen in
Fig. 23B and 23C, the Iki channel has a single activation gate regulated by
voltage driven activation and inactivation factors. In Fig. 23D, the activation gate
moved forward and upward with the AF state. Genetic linkage to AF is through
the KCNJ2 potassium subunit, a gain of function can cause the natural atrial
pacemaker function to be suppresses through lower membrane resting potential
and consequently quickens cell response to erratic currents.
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Fig. 23 Modeling outputs for Iki current are consistent with literature and drive
AF (A) time indepedndent Iki, (B) activation gate factor aki, (C) inaction gate
factor bki, (D) Iki activation gate SR and AF.

Transient outward potassium current Ito (down regulated 45%in AF) and
shown in Fig. 24A through 24C decreases as the AF factor increased. The
results, as seen in Fig. 24A, illustrated the decrease in a nonlinear manner from
SR to AF and a forward movement in the AP by approximately 100 ms. The
down regulated Ito aided the higher AP profile and propagation wave form. In Fig.
24B and 24C, Ito consists of fast activation and inactivation gates that are both
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time and voltage dependent. Both time constants have a squared factor that
quickens the Ito activity in the model. Given the significant change in Ito current,
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Fig. 24 Model output for Ito current drives AF as predicted (A) transient
outward Ito current, (B) Ito gate profile AF, (C) Ito gate profile SR.

the Ito gate profiles between SR and AF appear relatively stable. Ito conductance
is used to introduce the down regulation of the channel while the equilibrium
value was fixed. The AF genetic linkage is through loss of expression of KCND2
and KCND3 and is often driven by chronic α-adrenergic stimulation. Angiotensin
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II also reduces channel expression35. Both adrenergic and angiotensin II drive
blood pressure as a potential indicator. Linkage to AF allows for the shift to more
inward Na+ as the fast Ito outward is muted. This causes an increase in the AP
plateau and Ikp, which has the downstream effect of decreasing the electrochemical force of Ca2+ and ICa. This indirectly impacts the excitation-contraction
relationship in a negative manner as well as drives wave disturbances creating
and or facilitating other conditions for AF. Given the cascade effect of the Ito
channel and association with blood pressure indications, future tissue modeling
could focus more specifically to Ito and the opportunity for early detection of down
regulation.
Plateau potassium current Ikp – Ikp was not directly altered by the AF factor
but did respond to the system (Fig. 25A through 25C) with an approximate 10x
spike in equilibrium current and moved forward by 100 ms in the AP and
propagation wave. This impact occurs because the Ikp current and activation gate
are voltage driven and time independent, with the conductance and equilibrium
values fixed. As in the IKs current, the Ikp current is small in magnitude but does
impact the AP form. AF genetic linkage is generally assumed to be associated
with the understanding that Ito sets the Ikp activity level – i.e the level at which the
plateau is established. The “leveraged” effect, through voltage, of Ito on Ikp helps
explain the large jump in Ikp even without an AF factor. Elevated Ikp drives
positive membrane plateau current with potential impacts to drive higher IKs and
consequently higher resting potentials which enable faster tissue excitation and
the potential for re-entrant currents, rotors and other AF symptoms. In the
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literature, genetic conditions related to Ikp are often discussed as insignificant
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Fig. 25 Modeling output for Ikp current shows driving AF and impact to IKs (A)
plateau Ikp, (B) Ikp activation gate AF current, (C) Ikp activation gate SR.

contributor to AF development, however the tissue model demonstrates Ikp does
participate in AF.
Rapidly activating potassium current IKr shown in Fig. 26A through 26C, was
not impacted by the AF factor but did increase with the membrane potential
impact as well as stayed in-place relative to timing as compared to the IKi
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Fig. 26 Model output for IKr current shows impact of duel activation gates (A)
rapidly activating IKr currents SR to AF, (B) IKr gate profile AF, (C) IKr gate
profile SR.
currents. IKr was calculated with a dual gate model, one within the PDEPE solver
as a time and voltage dependent variable and the other as a time independent
rectifier gate. The equilibrium value was fixed and the conductance value was
driven by extra-cellular potassium concentration which was held fixed in the
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model. IKr is assumed to be compensated for by IKs in the Markov models
although it is still linked to AF. IKr is genetically linked to AF through its 4 identical
subunits encoded by HERG. Mutations of α-subunits KCNE2 and KCNH2 are
associated with Familial AF and the LQT and SQT syndromes and hence provide
leverage for potential early detection.
IKACh, – modeled in the acetylcholine challenge, is activated by muscarinic
receptors and called a muscarinic potassium channel. These channels are a
heterotetramer composed of two GIRK1 and two GIRK4 subunits. IKACh in the
heart, when activated by parasympathetic signals through M2 muscarinic
receptors, causes an outward current of potassium, which slows the heart rate.
Inward rectifier channel activation of IKACh hyperpolarizes the membrane potential
and abbreviates the action potential which was demonstrated in the validation
scenario challenge.
The model, in response to the AF factors, through a combination of Na+,
Ca2+ and K+ actions increases membrane voltage and initiates a cascade of the
K+ channel impacts that both heightens, through Ikur and Ito, and deepens,
through IKs and Ikp the AP form while shorting the APD through IKs. The
combination of these actions decreases wave propagation velocity and increases
the area of non-refractory tissue. The summation of the nonlinear responses of
the K+ channels provides the foundation for building potential early AF detection
tools. This concludes the discussion of the potassium ionic channel behavior in
the model and INa is now discussed because of it relevant impact.
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Sodium current INa is shown in Fig. 27 and 28. The INa current was not
directly altered by AF code, but did respond with a 2x increase in current,
standing almost in place during the AP and wave propagation. This pump current
would drive a corresponding higher sodium impact on the AP form and wave
propagation velocity helping explaining the higher electrical heart wave form the
model displays. This showed through in the Early AF Detection section as a
driver of earlier non-linear voltage gate driven model response. With the
exception of the addition of the late INaL component, Na+ was not a specific driver
of the model response but, once the AF stimulate was initiated, Na+ facilitated the
impacts in conjunction with the K+ channels. In Fig. 27C and 27D, the Na+
participation was accomplished primary through the slow inactivation gate j of the
model. While the genetic and kinetics of Na+ are not the subject of this study,
they do offer an opportunity for early detection and mediation of AF albeit the Na+
channels are not differentiated in the atrial chamber tissue to the same extent as
are the K+ channels.
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Fig. 27 Model output for Na+ current shows the impact of the Slow inactivation
gate (A) INa h fast inactivation AF, (B) INa h fast inactivation SR, (C) INa j slow
inactivation AF, (D) INa j slow inactivation SR.
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Fig. 28 INa current cont’d. (A) INa current SR – AF, (B) INa m activation AF, (C )
INa m activation SR.

3.8 State Variables and All Ionic Flows
Fig. 29 illustrates the SR to AF state current comparisons and Appendix E
illustrates the state variables in both SR and AF, and Appendix F lists the tissue
model variables. The charts provides a summary graphic overview of the ionic
flows in the model comparing the SR and AF states for 19 ionic
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Fig. 29 SR to AF Ionic current comparisons – all Ionic flows
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currents and for the 58 state variables in the model.
In Fig. 30 for the ICaCl, Ca Flux and Incx exchanger currents, the Na+ and Ca2+
currents provide further definition of the AF AP wave form and associated
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Fig. 30 ICaCl, Ca flux and NaCa exchanger currents (A) ICaCl current SR – AF,
(B) Ca flux flows, (C) Incx exchanger current.

propagation velocity. The Incx exchanger is driven by the sarcolemma and
junctional sodium to calcium binding factors that are in turn driven by membrane
potential and sodium and calcium intra compartmental concentrations. The
binding kinetics terms are all defined with nonlinear terms such as factors raised
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to the 3 power which further drives the Incx response in the model. Late sodium
channels, inactive in SR and active in AF, contribute to the model response of
the Incx channels as well. The increased sodium then drives the response in Ca 2+
channels. The ICaCl current, although small is driven by membrane potential and
binding factors. Finally, the introduction of the AF factor in the Na+ and Ca2+
association, disassociation and binding factors contributes to the AF current
profile exhibited in the AP form.
3.9 Safety Factor
As reported in other studies76,77 the Safety Factor calculation (Fig. 31),
provided inconsistent results throughout the modeling process although generally
in the relative range of values. The conditions the model was intended to create
were not necessarily consistent with the conditions which the safety factor would

Fig. 31 Safety of Propagation Factor14

provide the predicted otucomes14,74. In most safety factor analysis the conduction
velocity slowed, which it increased in these simulations. Also, gap junctions
increased and in these simulations gap junctions decreased. These are not
contradictory outcomes as these difference limitations are discussed in literature
with the application of the safety factor14, 64,65,74,76. Consequently, at times the
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calculation would present the AF wave propagation as more secure due to the
higher peak action potential and the fixed basic cycle time. While the calculation
appeared to be correct, the intended use as an early AF detection tool proved to
be of limited value. As the modeling project developed and progressed the lack
of correlation “physical” wave form led to the shelving of the concept for AF
detection. In particular the project objective was to find detection methods prior to
when the physical wave propagation would be physically impaired. However the
methodology of calculating the Ionic currents provided a novel method to insert
the safety factor calculations. In a future modeling effort based on a tissue
correlated parameters the Boyle et al.76 model could be incorporated.
The methodology of the modeling suggests, and the preliminary output of the
model confirmed that the safety factor actually increased during the progression
to AF as a result of the deeper and higher propagation wave form developed.
Theory suggests that if the model could represent the actual wave break, that a
decrease in the safety factor would occur as the wave disintegrated at the point
of singularity.
Results for external cell geometry, external diffusion, and internal cell
conditions are discussed in the appendices.
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Chapter 4 Discussion
4.1 General
The hypothesis was made that a human atrial tissue model could be
developed to aid in the potential early detection and treatment of atrial fibrillation.
The modeling demonstrates the potential to use signal analysis type
characterization to identify patterns of the electrical heart wave that can be
associated with the risk of developing human atrial fibrillation.
The human atrial tissue model was responsive to the human SR inputs, as
defined by Grandi et al.23 and demonstrated stability as Livshitz et al.12 described
in utilization with a canine ventricular application.
Overall the model provided a definitive response and characterization of
atrial fibrillation in the human atrial heart. The sinus rhythm (SR) characterization
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Fig. 32 Membrane potential plot (A) tissue membrane potential plot – SR, (B)
tissue membrane potential plot – AF.
(Fig. 32A), in terms of APD, refractory periods, propagation velocity, action
potential upstroke velocity, maximum and minimums was stable and provided a
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baseline against which other physical alterations of the human atrial cell could be
compared.
As compared to the SR state, the AF alteration of the cardiac ionic states and
flows in the model, as defined by Grandi et al.23 provided a pattern of AF, Fig.
32B, that includes quickened AP, reduced APD, reduced propagation velocity, as
illustrated in Fig. 33A, and increased non-refractory tissue. The model output
created by geometrical variations of the cells had much less response from the
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Fig. 33 Model outputs (A) tissue propagation velocity, (B) comparative
propagation velocity Outputs, (C) K+ currents SR, (D) AP view of
propagation walk (on time mesh scale).
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SR state (Fig. 33B), in terms of APD, propagation velocity and other
characteristics. The differentiation between ionic driven AF and the geometric
manipulation of the human atrial cell was consistent throughout the
characterization variables. Fig. 33D provides an AP flow in the same direction of
the membrane plots and illustrates the shift of AP, APD and implied propagation
in AF. The definition of human atrial fibrillation executed in the human atrial
tissue model structure, suggests that early human AF detection via signal
analysis is a distinct possibility as the model nonlinear response in early AF was
distinctive. This observation is a particularly important in the model output for
potential predictive uses. The tissue model responded as expected, in both SR
and AF states, to known drug treatments, AVE0118 and acetylcholine, utilized in
the treatment and study of AF. The AF characterization variables, shown as
model outputs in Table 4, were consistent throughout the various stages of AF
modeled and, if truly replicative of potential human conditions, could be used to
predict potential AF development with the caveat that further correlation with
human cardiac atrial tissue is required.
The model provided definitive characterization of potassium currents in SR
(Fig. 33C) and for the various stages of AF development. While the SR versus
AF from Grandi et al.23 represents a seemingly straight forward adjustment to
state variables the modeling indicated predicting actual ionic results can be
difficult as buffers and other cellular elements responding to the inputs.
Finally the modeling represents an extensive array of ionic current flow and
state gate data, with 59 state variables, 18 unique ionic currents, as shown in
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Appendix D, and advanced sodium and calcium buffers. With the excitationcontraction coupling expressed through the Ca2+ ionic flows, fluxes, and
concentration buffers, the Human Atrial Tissue model has, with appropriate
correlation to human data, potential significant uses for other hypotheses
concerning atrial fibrillation, its detection and its management.
4.2 Wave Break
Further analysis can be done by running the model on a 16 or 32 BCL split
tissue iteration that can allow for calculation of the angle of wave break, as in Fig.
35A and 35B31, to model tissue area versus the opportunity for rotor
development. Fig. 34 provides more illustration of the developing break angle.
The break angle is believed to eventually degrade along with the AP form and

Fig. 34 Split State Tissue Membrane with Potential Wave Break Angle
Development.
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extended non-refractory periods into forms of AF in the tissue. Fig. 35A can be
overlaid on Fig. 34 to illustrate the potential wave break developing in the model.
As discussed below in external diffusion impacts, different numerical
methods identified in this study but not included in the report, could be used to
model both distance and time step functions based on the AF inputs used in this

A

B

Fig. 35 Tissue inhomogeneity rotor development (A) wave break angle, (B)
wave to rotor31.
study.
Finally the PDEPE solver was challenged to calculate a 3 mode model such
as SR to AF to SR which would provide an additional situation potentially
representative of early cardiac remodeling. The numeric methods embedded in
the PDEPE solver, for this study, could not estimate the additional step change
and therefore the multiple step modeling was stopped. Future model code could
be developed to potentially provide this functionality.
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Additionally, the model illustrated the ability to represent transition zones,
representing those areas where the human tissue transitions from SR to AF
conducive properties. In Fig. 34 the propagation wave can also be distinctively
characterized at those boundaries with the same wave properties. The output
differential in the transition zones can be correlated to the mathematical
properties of the wave breaks and rotors to potentially create more advanced
modeling scenarios that represent the human experience phenomenon.
4.3 Rolling Pulse
One additional item noted for further attention in future studies is the
phenomenon of pulses rolling over BCL time frames, in Fig. 36, which shows a
cross BCL membrane potential plot, as an example of further potential
opportunities identified in this study. The analytics extract could have been
designed around dynamic pulse selection although the results interpretation
would be more complex. However the method of taking the last t values across
all x in the model solution allows the model to run indefinitely assuming the
human tissue correlation is done and the model stability persists. Output run in
this manner suggested that with split tissue scenarios and further extended
distance, such as 400 cells, the model may show characteristics of discontinuous
propagation similar to emulating initiation of AF.
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Fig. 36 Extended tissue membrane potential plot – model extended by taking
8 pulse continuous event runs and “appending” via final time slice as initial
conditions t0 for next run.

4.4 Novelty
The project is unique and innovative in that it transforms a known validated
cell model developed by Grandi et al.23 into a tissue model that can be
used/leveraged to help develop potential early detection methods for AF to delay
or prevent AF associated cardiac remodeling. This model incorporates some of
the most advanced cardiac cell structures in a packaging that offers reasonably
quick iteration time and can be modified for use regardless of the physiology of
the particular form of AF. To date there are few models focused, based on the
complex and complete cardiac cellular structure, on establishing a starting point
for AF analysis in tissue.
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4.5 Next Steps
The next steps would be to calibrate the model with actual human atrial data
to validate all outputs of the model. This step would provide a level of accuracy in
the model that would enable meaningful studies long duration, 1-5 minutes,
analysis of larger tissue strips, up to 1 X 10 cm is size. The utilization of
advancements in Langendorff phenotyping85 to further refine existing and
additional cell kinetics could further support the early AF analysis with both better
cell definition and identification schemes based on the preponderance for AF on
genetic basis.
Further, leveraging analytical outputs of optical mapping, Langendorff
ejecting heart preparations32,85, and electrocardiographic imaging with the model
ion channel kinetics could enable a more advanced model elements to predict
electrical wave patterns of arrhythmias. Correlation with electrocardiographic
imaging tools can also potentially provide predictive analysis capabilities to the
model.
Leveraging electrocardiographic imaging tools to improve the tissue
modeling would potentially enable focus on analyzing the characteristics of early
heart development as well as modeling the initial characteristics of the
development stage of AF in the young human heart. The advantage of the tissue
model detail is that its flexibility is still maintained albeit with significant
complexity. The flexibility of the complex tissue model can enable simultaneous
modeling of multiple stages of the young human atrial development in a manner
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which can be useful in determining the potential sequence by which humans
develop AF event at the ion channel level.
Beyond enhanced kinetics and cell definition, incorporation of ephaptic
concepts84 in the model would be a significant step in potential understanding of
how the heart wave propagates and mysteriously reappears within non-refractory
or near non-refractory tissue structures. The incorporation of equations that can
model potential ephaptic effects84 of cell to cell conduction in particular in relation
to the tissue refractory opportunities would be a significant step towards a 3D
model more suited for Finite Element and bidomain modeling tools but still at a
much more advanced cell kinetics definition. Understanding ephaptic effects
through tissue modeling also offers insight into the application of current
pacemaker technology applications in order to reduce the adverse effects and
improve their efficacy.
At the modeling level, development of geometric relationships in the cell
models relative to channel proximity and cell size can potentially enable analysis
and tissue modeling of the role of ischemia proximity tissue in AF and adverse
development characteristics. The current model lacked this functionality but it
can, with modest detail incorporate such functionality to the extent that actual
human atrial data could be used to calibrate the state variables.
Further development of AF definitions for use as predictors to be modeled as
potential clinical screening applications are a vital next step in the early detection
of developing AF. The current model made use of a scheme that, while relevant
for the study, needs clinical verification to have clinical validation. This model
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also used a scheme for classifying early AF, 25% of the AF adjustments, that
also needs clinical foundations. The model assumed a logical progression of AF
but can easily adapt to non-linear and less straightforward approaches to the
early stages of development of AF analysis where efforts can be directed.
Additionally, given the suggestions of further enhancements and flexibility of
the tissue model as run for this study, it would only be logical to explore the
application of the cell model to 3D models such as Finite Element tools and or
the Bidomain models. Models built on parallel processing platforms or on
software leveraging the advances in electronic computing hardware, native 64 bit
application code and advanced MATLAB code offer opportunities for the fast turn
scenario analysis on a more advanced model upon which the
electrocardiographic imaging could be correlated with.
Finally, the human atrial tool as developed can be integrated as a tissue
model, where current cellular models are used21,29,30,31, for integrated AF analysis
with 3D tools, rotor and wave analysis and electrocardiographic imaging to
further the understanding and predictive abilities in AF.
4.6 Model limitations
The human atrial tissue model proved to be stable and provided consistent
results primarily from the standpoint of arrhythmia development23,26,28. The model
does have limitations that in some cases can be addressed and in other cases
are inherent to Silico modeling. Addressable limitations include complexity, the
model is 60 state variables, 19 ionic currents (more in the AVE0118 and
acetylcholine challenges), and 4 layers of coding. The model is very appropriate
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for the AF analysis challenge but the results require a level of verification well
beyond most of the cardiac models in literature. The model was not run on a
parallel processor platform but can be – the run time, even on advanced desktop
devices is over 3 hours and significantly greater for extended versions of the
model. With such run times specific modeling becomes tedious and error prone.
The MATLAB code is much improved in the R2014a versions relative to resource
management and function call for PDEPE but still lacks an informative user
interface for the activities of the numeric solver hence the range of values from
10e+3 to 10e-7 in the calculations can create potential errors or nuances. The
tissue model initial conditions are from a cellular model by Grandi et al.23 and
extrapolated linearly for a tissue model, which while not necessarily incorrect,
suggests an improvement by using physiological data from a two or three
dimensional set up and output. The model needs human left atrial data to
validate the kinetic equations, confirm the constants values and verify the model
output. The model propagation velocity is slow for human atrial tissue which
implies a fixed BCL may not be an optimal setup. The diffusion equation structure
of the model is one of the most promising concepts but limited by the lack of
correlation to human data. The model output suggests limited correlation
between diffusion and AF characteristics however in real human atrial conditions
the diffusion factor can be expected to be correlated with initial conditions of
several state variables and model constants such as cellular concentrations.
Finally, from an In Silico perspective, the model mathematics by definition are not
independent functions such as in real human atrial conditions and therefore will
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not necessarily represent the spontaneous outputs experienced in real human
atrial tissue. The cause and effect conclusions from the results must be always
be evaluated with that caveat.
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Chapter 5 Conclusions
The Tissue model study resulted in 10 findings: 1) the model can represent
both SR and AF conditions with corresponding wave form propagation, 2) the
model can be validated against several other studies, 3) early AF, defined as the
period between 0% AF factor and 25% AF factors applied, expresses the same
characteristics but with much greater challenges in external wave form analysis
of the rate of change, 4) external cell geometric changes on SR state tissue have
much less significant impact on the model relative to analyzing AF conditions, 5)
the model is able to represent split tissue conditions, primarily from SR to AF
conditions and therefore potentially represent “at risk” boundary conditions
capable of creating rotor conditions, 6) external diffusion coefficient changes,
representing gap junctions, on SR state tissue have smaller but important
directional impact on the model relative to displaying AF conditions 7) possibly
due to the calcium and sodium buffering/complexity, internal cellular geometric
changes on SR state tissue have much smaller impact on the model relative to
displaying AF conditions, 8) likely conditions for membrane potential driven
channel remodeling can be modeled and analyzed, 9) the model displays
consistent but moving ionic states and conditions throughout the progression
from SR to AF tissue state, and 10) isolated ionic conditions can provide analysis
opportunities for specific wave patterns. The elements used to analyze AF
condition include left atrial14,17,29,46,47, epicardial86 heart tissue, ion channel
specificity and expression35, comprehensive excitation contraction calcium and
sodium kinetics, and time distance modeling. The modeling was validated based

88

on a complex but realistic cell model calibrated to human left atrial tissue. The
model demonstrated stability over time in wave form and ionic kinetics, provided
wave form output that not only aligned with expectations from literature, but also
provided a rich basis upon which atrial fibrillation based wave analysis could be
accomplished.
The model suggests AF, through ionic kinetics, can be represented by a
heightened AP, shorted APD, decreased wave propagation and increased non
refractory tissue area. Further the tissue model does not contradict the concept
that gap junctions are a significant contributing factor to AF. It is theorized the
model construct did not account for the association/disassociation kinetic
functions that would logically tie the diffusion coefficient, the mathematical
representation, of the gap junctions to the geometry and diffusion coefficient
change variation modeling hence a key correlating result were not seen.
However there was model movement in the expected direction with pure diffusion
coefficient variation.
Human and experimental studies have shown that effective shortening of the
AP refractory period, the period when the cardiac tissue cannot be depolarized,
is an essential feature of atrial fibrillation17. The human atrial tissue model, as
discussed, replicates that phenomenon as a logical extension of the wave form
change – AP height and depth, and wave propagation changes and also reflects
channel pathologies. The model provided ionic channel detail to potential genetic
linkage though activation and inactivation factors.
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AF has been characterized as having focal triggers in the pulmonary vein
interface within the heart and left atrium36. The triggers manifest themselves as
early after depolarization (EAD) and delayed after depolarization (DAD) with
associated electrical waves. The tissue model demonstrated the potential to
represent tissue environments required to facilitate EAD and DAD though
increased wave height and non-refractory area growth. Maintenance of AF is
through wave breaks and associated points of singularity (PS) in heterogeneous
tissue. The tissue model was able to replicate, via the split tissue scenario, how
wave breaks and points of singularity could be generated which in turn would
create the environment for rotors. The model provides a logical basis upon which
a 3D model could be built in an effort to show reentrant points as a result of the
wave breaks. Finally, the model provides a realistic human atrial tissue in Silico
representation, albeit with complex structure, and has potential for use in related
studies. The significance of a tablet or desktop model is the element of low cost,
extensible applications and general public access to the technology.
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Appendix A. Model Progression
Model Progression 23
Atrial Vs Ventricular

cAF Vs Base Atrial

Lone Atrial Fibrillation

Ionic Currents
Ina

Unchanged

-10% peak density

Unchanged from base ventricular

InaL

Not in model

Added Late Component

Unchanged from base ventricular

IKs

Unchanged

Increased 2-fold

Gain of function from base atrial

IKr

Unchanged

Unchanged

Loss of Function from base atrial

IKur

Added

-55% in the RA

Loss of Function from Base atrial

-45% in the LA

Iki (IK1)

85% Reduction

Upregulated +100%

Loss of Function

Ito

No Itos

Itof

Gain of Function

Itof
Activation and inactivation negatively
shifftede and slower inactivation;
larger amplitude

-80% in the RA
-45% in the LA

Ca and Na Handling

ICaL
Incx
SERCA

Matched amplitude and
kinetics at 37 deg
Atrium < ventricle (-30%)
Kd,act increased by 50%
No chnges in mximal oump rate
Kmf increased 2-fold

Current density is reduced by
50% in cAF. No Chnages in
voltage dependence of
activation and inactivation

Unchanged from base ventricular

Upregulated in cAF (+40%)

Unchanged from base ventricular

Reduced maximal pump rate

Unchanged from base ventricular

RyR

unchanged

Increased sensitivey for
luminal Ca2+ (2 fold)

Unchanged from base ventricular

SR Ca2+ leak

unchanged

Increased by 25%

Unchanged from base ventricular

Tnl

unchanged

Unchanged

Unchanged from base ventricular

INak

Atrium < ventricle (-30%)

Unchanged

Unchanged from base ventricular
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Appendix B. The Genetic Basis of Inherited Arrhythmias
The Genetic Basis of Inherited Arrhythmias 37
Type
LQTS
LQT1
LQT2
LQT3
LQT4
LQT5
LQT6
LQT7
LQT8
Short QT syndrome
S4T1
S4T2
S4T3
Brugada syndrome
BrS1
BrS2
BrS3
BrS4
BrS other
Catecholaminergic polymorphic VT

Gene

Protein

Functional Alteration

KCNQ1
KCNH2
SCN5A
ANK2
KCNE1
KCNE2
KCNJ2
CACNA1C

I Ks potassium channel α-subunit
I Kr potassium channel α-subunit
I Na cardiac sodium channel α-subunit
Ankyrin-B
I Ks potassium channel β-subunit
I Kr potassium channel β-subunit
Iki (I K1 ) potassium channel subunit
Calcium channel α-subunit

Loss of function
Loss of function
Gain of function
Loss of function
Loss of function
Loss of function
Loss of function
Gain of function

KCNH2
KCNQ1
KCNJ2

I Kr potassium channel α-subunit
I Ks potassium channel α-subunit
Iki (I K1 ) potassium channel subunit

Gain of function
Gain of function
Gain of function

SCN5A
GPD1L
CACNA1C
CACNB2b
ANKRYN-B

I Na sodium channel α-subunit
G-3PD 1I Ca calcium channel α-subunit
I Ca calcium channel β-subunit
Ankryin-B

Loss of function
Altered function
Loss of function
Loss of function
Altered function

RYR2
CASQ2

Cardiac ryanodine receptor
Calsequestrin

Gain of function
Gain of function

HCN4
SCN5A

I f pacemaker channel subunit
I Na cardiac sodium channel α-subunit

Loss of function
Loss of function

SCN5A

I Na cardiac sodium channel α-subunit

Loss of function

KCNQ1
KCNE2
KCNJ2
KCNH2

I Ks potassium channel α-subunit
I Kr potassium channel β-subunit
Iki (I K1 ) potassium channel subunit
I Kr potassium channel α-subunit

Gain of function
Gain of function
Gain of function
Gain of function

Idiopathic sick sinus syndrome

Cardiac conduction disease
Familial atrial fibrillation
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Appendix C. Definitions and Abbreviations

CTKCL

Definitions and abbreviations12,23,26,28,35
K+-CL- cotransporter, mmol/L per ms

CTNaCl

Na+-CL- cotransporter, mmol/L per ms

ICab

Background Ca2+ current

IpCa

Sarcolemmal Ca2+ pump

INa

Inward Sodium Current (Fast Na+ current)

INAL

Inward slow Sodium Current (slow Na+ current)

ICaL

Inward L-type Ca2+ current

ICLCa

Ca2+ activated Cl - current

Ikr

Rapid delayed rectifier K+ current

Iks

Slow delayed rectifier K+ current

Ito

Transient outward K+ current

Ito1
Itr

4AP-sensitive transient outward K+ current
Ca2+ transfer from NSR to JSR, mmo;/L per ms

IK1 = IKi

Time-independent K+ cuurent

Ikur

Ultr rapid delayed rectifier K+ current

IKACh

(Acetylcholine) Muscarinic-gated K+ current

INaK

Na+/K+ pump current

Irel

Ca2+ release from JSR to myoplasm mmol/L per ms

Incx

Na+-Ca2+ exchanger

SERCA
SR
CaMKII
PLB
JSR
NSR
CSQN
RyR
ATP

Sarcoplasmic reticulum Ca2+ ATPase
Sacroplasmic reticulim
Calcium/Calmodulin-dependent Protein Kinase II
Phospholamban
Junctional sarcoplasmic reticulum
Network sarcolplasmic reticulum
luminal buffer calsequestrin
Ryanodine receptor
Adenosine 5'-triphosphate
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Appendix D. Human Atrial Tissue Model Current and Fluxes
Current
I_Na
I_NaL
I_nabk
I_nak
I_kr
I_ks
I_kp
I_to
I_kur
I_ki
I_ClCa
I_Clbk
I_Ca
I_CaK
I_CaNa
I_ncx
I_pca
I_cabk
SR fluxes
J_SRCarel
J_serca
J_SRleak
J_CaB_cytosol
J_CaB_junction
J_CaB_sl

Subcomponent
I_Na_junc
I_NaL_junc
I_nabk_junc
I_nak_junc

I_Na_sl
I_NaL_sl
I_nabk_sl
I_nak_sl;

I_ks_junc
I_kp_junc

I_ks_sl
I_kp_sl

I_Ca_junc

I_Ca_sl

I_CaNa_junc
I_ncx_junc
I_pca_junc
I_cabk_junc

I_CaNa_sl
I_ncx_sl
I_pca_sl
I_cabk_sl

Description
Fast Na
Late I_Na
Na Background Current
Na/K Pump Current
Rapidly Activating K Current
Slowly Activating K Current
Plateau K current
Transient Outward K Current (slow and fast components)
Ultra rapid delayed rectifier Outward K Current
Time-Independent K Current
Ca-activated Cl Current
background Cl Current
L-type Calcium Current
K/Ca Pump
Na/Ca Pump
Na/Ca Exchanger flux
Sarcolemmal Ca Pump Current
Ca Background Current
Sacroplasmic Reticulim Calcium Release
Sacroplasmic Reticulim Ca pump
Sacroplasmic Reticulim Ca leak
Cytosolic Ca Buffer
Junctional Ca Buffers
sarcolemma Ca Buffers

Note current grammatical syntax is based on MATLAB code.
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Appendix E. State Variables SR – AF Part I
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Appendix E. State Variables SR – AF Part II
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Appendix E. State Variables SR – AF Part III
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Appendix E. State Variables SR – AF Part IV
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Appendix F. Tissue Model Variables Part I

Variable
Y1
Y2
Y3
Y4
Y5
Y6
Y7
Y8
Y9
Y10
Y11
Y12
Y13
Y14
Y15
Y16
Y17
Y18
Y19
Y20
Y21
Y22
Y23
Y24
Y25
Y26
Y27
Y28
Y29
Y30
Y31

Variable
Name
mo
ho
jo
do
fo
fcaBslo
fcaBslo
xtoso
ytoso
xtofo
ytofo
xkro
xkso
RyRro
RyRoo
RyRio
NaBjo
NaBslo
TnCLo
TnCHco
TnCHmo
CaMo
Myoco
Myomo
SRBo
SLLjo
SLLslo
SLHjo
SLHslo
Csqnbo
Ca_sro

Variable Description
sodium activation gate
sodium fast inactivation gate
sodium slow inactivation gate
Calcium d activation gate
Calcium f activation gate
calcium junction inactivation
calcium sarcolemmal inactivation
to slow activation rate - not used
to slow inactivation rate - not used
to fast activation rate
to fast inactivation rate
kr open channels
ks open channels
RyR inactivation rate
RYR open state
RYR closed state
Sodium concetration junctional buffering
Sodium concetration sarcolemmal buffering
Ca concetration in tropin C low state
Ca concetration in tropin C high state
Mg concetration in tropin C high state
Ca concetration in Calmodulin
Ca concetration in Myosin
Mg concetration in Myosin
Ca concetration in sarcoplasmic reticulum
Ca concetration in junction low state
Ca concetration in sarcolemma low state
Ca concetration in junction high state
Ca concetration in sarcolemma high state
Calsequestrin buffer concentration
Ca concetration in sarcoplasmic reticulum
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UOM

mM
mM
mM
mM
mM
mM
mM
mM
mM
mM
mM
mM
mM
mM
mM

Appendix F. Tissue Model Variables Part II

Variable
Y32
Y33
Y34
Y35
Y36
Y37
Y38
Y39
Y40
Y41
Y42
Y43
Y44
Y45
Y46
Y47
Y48
Y49
Y50
Y51
Y52
Y53
Y54
Y55
Y56
Y57
Y58
Y59
Y60
Y61
Y62

Variable
Name
Najo
Naslo
Naio
Kio
Cajo
Caslo
Caio
Vmo
rtoso
AVE
C1o
C2o
C3o
C4o
C5o
C6o
C7o
C8o
C9o
C10o
C11o
C12o
C13o
C14o
C15o
O1o
rkuro
skuro
ml
hl
nalo

Variable Description

UOM

Sarcolemmal sodium concentration
Junctional sodium concentration
intracellular sodium concentration
Junctional calcium concentration
Ca concetration in junction
Ca concetration in sarcolemma
intra cellular calcium concentration
Membrane voltage
reserve to slow concentration - not used
voltage dependent Ikur blocked gate
C1o channel with 4 closed units
C2o channel with 3 closed and 1 intermediate units
C3o channel with 2 closed and 2 intermediate units
C4o channel with 1 closed and 3 intermediate units
C5o channel with 4 intermediate units
C6o channel with 3 closed and 1 activated units
C7o channel with 2 closed, 1 intermediate and 1 active units
C8o channel with 1 closed, 2 intermediate and 1 activated units
C9o channel with 3 intermediate and 1 activated units
C10o channel with 2 closed and 2 activated units
C11o channel with 1 closed, 1 intermediate and 2 activated units
C12o channel with 2 intermediate and 2 activated units
C13o channel with 1 closed and 3 activated units
C14o channel with 1 intermediate and 3 activated units
C15o channel with 4 activated units
O1o channel open early
kur activation rate
kur inactivation rate
late sodium activation gate
late sodium inactivation gate
late sodium concentration
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mM
mM
mM
mM
mM
mM
mM
mV
mM

mM

Appendix G. External Cell Geometry
A

B

C

D

Fig. 37 Geometric variation of cell size modeling outputs (A) geometric
variation APD, (B) geometric variation mean maximum potential change, (C)
geometric variation propagation velocity, (D) geometric variation cell
diagram28 Modified. SR value for length on green line = 100 µm. SR value for
radius on green Line = 10.25 µm

The model is held at SR as a baseline to see if the geometric changes
“mimic” AF. With the model tissue state at SR the cell length was varied from 75
to 200 µm and the radius from 8.25 to 13.325 µm with little if any impact on the
SR state of the tissue and less than 25% change in propagation velocity as seen
in Fig. 37A through 37D and rows 6 and 7, in Table 6. Since the model showed
stability and the output variables all displayed the same characteristics, only
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three output variables, APD, Mean Maximum Membrane Potential Velocity and
Propagation Velocity are shown. Reducing the cell radius and length marginally
increased the propagation velocity while the expanding the radius and length had
insignificant change impact on the tissue SR state. From these observations and
settings, the conclusion is drawn that at a macro level cellular geometry alone,
within the tissue structure is not a driver or detectable measure of AF with this
particular model. This is substantiated by the review of state variables from SR to
AF in Appendix E as the external geometries provided only indirect input to
channels states. The external geometries can influence buffer states and
capacities through resulting impacts on internal cellular diffusion, channel
densities and resulting ionic ratios if the functional relationships are known and
modeled. One of the key features of the model is the adaptive calcium and
sodium buffers which potentially mask changes driven by geometric factors.
Further research85 in the study addresses the impacts of internal cellular
variations in the cytosolic, junctional and sarcolemma geometries and diffusion
characteristics as model study elements with similar results. While cell length and
radius are contained in several Ca2+ and Na+ equations, there is no direct
functional tie to channels per volume connecting external dimensions to internal
cellular states.
A review of Fig. 37C, with the green line (graduated AF) SR states for each
variable conveniently aligned at the same AF step, does suggest that reducing
the geometries may lead to lengthened APD, a directional shift opposite of this
study but potentially of further study value.
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Appendix H. External Diffusion Coefficient

A

B

C

Fig. 38 Modeling variable outputs for diffusion factor changes (A) external
diffusion propagation velocity, (B) external diffusion APD, (C) external
diffusion mean maximum membrane potential change.

In Fig. 38A through 38D, comparison of the baseline SR to AF model to
changes in diffusion coefficient and internal cell stimulation per the Livshitz et
al.12 model was thought to recognize the impact of the diffusion coefficient on
representing the physical impact of gap junctions on AF. The diffusion factor was
set to increase, in comparison to the decrease in the split tissue scenario, to
represent another potential form of cardiac pathology related to AF14. The
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diffusion factor for this model was independent of the flux and ionic current
adjustments in the cell component of the human atrial tissue model. In row 8,
Table 6, propagation velocity change, while directionally aligned at 18%
reduction was less than 25%. Reference the comments in external geometry
analysis, the atrial tissue model is stable and the model outputs were consistent
therefore only APD, wave propagation velocity and AP velocity are shown. The
change in propagation velocity was theorized to be attributed to the impact of the
increased axial current on the model structure of the Incx and INa channels which
respond to the membrane voltage change driving the AP form, similar to the Na +
and Ca+ only changes discussed earlier.
The diffusion factor, theoretically measuring the availability and or impact of
gap junctions on the propagation velocity and electrical wave characteristics, was
varied between a value of .0035 to .0275, i.e. a magnitude of 10, and showed
impact on the SR state of the tissue through downward trending propagation
velocity. The diffusion factor was increased in this scenario to represent current
moving between cells with less control (gap junction structure) which is opposite
from the direction in the split tissue scenario. It is worthy to note the diffusion
factor, at a value above .0350 caused propagation failure. This is taken as
confirmation the diffusion factor is driving model albeit not as intended without
functional relationships between the coefficient and the internal cell workings.
Comparison to the Livshitz et al.12 model supplemental information is not clear as
to the directional impact to be expected given the impact of the kinetics
mathematics.
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As discussed earlier, for the diffusion coefficient impact, there are multiple
factors not taken into consideration in this model – location of channels, a
functional relationship between diffusion and half saturation constants that would
make the cellular geometry and diffusion coefficient nontrivial factors in the AF
output metrics. Additionally, the modeling by design, was intended to maintain
stability through the various calcium and sodium buffers. The Livshitz et al.12
model did offer a path to a more integrated diffusion function through the
𝑟

1

1

𝑚
formulation 𝜆2 = (𝑟 +𝑟
) = 𝐷 = 1/(𝜎 + 𝜎 )/𝑐m which in a future study could
𝑖

𝑜

a

g

correlate an intra-cellular conductance function with the relevant
associations/disassociation constants within human cellular conditions as well as
the relationship between geometry and diffusion.
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Appendix I. Internal Cell Conditions

A

B

C

D

Fig. 39 Intra cellular geometry modeling results (A) intra cellular geometry
APD, (B) intra cellular mean maximum membrane potential change, (C) intra
cellular geometry propagation velocity, (D) intra cellular geometry changes
diagram28 Modified.
As in the discussion on external cellular geometry and diffusion coefficient
changes, the speed of internal junctional ion diffusion and size of the junctional
area relative to total cell size did not drive model output of discernable difference
from SR conditions as illustrated in Fig. 39A through 39D. The junctional volume
and sarcolemma to junctional and cytosol diffusion changes where intended to
represent an internal cell modification representative of a potential form of early
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remodeling. In rows 10 and 11, Table 6, neither scenario change propagation
velocity by 25% and in fact were 0. Because the atrial tissue model was stable
and outputs consistent, only the APD, wave propagation velocity and AP velocity
are shown. As in the other nonionic impact analysis discussions the lack of
functional connection between the conditions modeled and the internal cell
structure and the design of the model through calcium and sodium buffers likely
precluded and impact on the output parameters driven by AF. State variables,
ionic currents and model outputs remained nearly constant throughout the model
iterations over the range of geometrical values. The consolidated review of
literature did not, from a practical point of view, discuss heart tissue conditions
such as those modeled in this manner since if they existed at birth with AF
associated ionic factors, they would probably be detectable immediately.
However the possibility exists that these physical conditions, if existing, could
facilitate remodeling of normal ionic channels into AF associated conditions. That
analysis is beyond the scope of this study.
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Appendix J. Sample Summary Scenario Data Sets
SR to AF Scenario Model Data Set
1
Input Change Variable
SR
Refractory
0.571714
APD
513.9438
MaxTMP
324.97
MinTMP
288.0463
MaxDeltaTMP
309.0438
RangeTMP
85.73743
Maximum
10.79565
Minimum
-74.9678
ChangeTMP
14.64519
Prop Velocity
9.2
MATLAB ARRAY DATA

Model Iteration
2
3
4
.25AF
.50AF
.75AF
0.578078 0.589785
0.6179
506.3063 492.2575
458.52
329.9225 324.5025 313.7313
293.5263 293.4213 289.6113
314.8638 313.7575 304.1725
83.68445 81.9602 80.96917
8.710775 6.927469 5.859629
-74.992 -75.0456 -75.1186
14.2773 14.00437 14.02187
8.93
8.43
7.68

5
AF
0.66781
398.6275
299.0338
288.3775
290.415
80.42415
5.251713
-75.1795
14.05201
6.94

Scenario Output Variable Comparison to AF
Input Change Variable
Baseline Prop Velocity
Senario Prop Velocity
Chart Data

Report Out Against Baseline
SR
.25AF
.50AF
9.2
67.12
4.66
9.2
8.93
8.43

.75AF
3.95
7.68

AF
3.58
6.94

Variable Scenario Model Data Set
Model State SR
Input Change Variable

Refractory
APD
MaxTMP
MinTMP
MaxDeltaTMP
RangeTMP
Maximum
Minimum
ChangeTMP
Prop Velocity

1
75
0.573156
512.2125
346.6288
307.4125
329.5275
85.39157
10.62383
-74.7965
14.39863
10.36

Model Iteration
2
3
4
90
100
150
0.572864 0.571713 0.560797
512.5638 513.945 527.0438
330.615
324.97 326.5625
293.1413 288.0463 289.6313
314.3863 309.035 310.6513
85.6561 85.73741 85.67706
10.76883 10.79562 10.66131
-74.9148 -74.9678 -75.0346
14.45057 14.64521 14.5471
9.54
9.2
8.74

5
200
0.545119
545.8575
356.1988
315.7713
337.765
85.02473
10.12945
-74.9099
13.93712
9.23

MATLAB ARRAY DATA

Scenario Output Variable Comparison to Baseline – Input Variable increment/decrement
Report Out Against Baseline
SR
.25AF
.50AF
Baseline Prop Velocity
9.2
67.12
4.66
Input Change Variable
75
90
100
Senario Prop Velocity
9.2
7.47
5.74
Chart Data

.75AF
3.95
150
4.57

AF
3.58
200
3.88
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